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Trachoma, caused by Chlamydia trachomatis, is the world’s leading infectious cause
of blindness and remains a significant public health problem. Much of trachomatous
disease pathology is thought to be caused indirectly by host cellular and immune
responses, however the immune response during active trachoma and how this initiates
progressive scarring is not clearly understood. Defining protective vs. pathogenic
immune response to C. trachomatis is important for vaccine design and evaluation.
This study reports the baseline results of a longitudinal cohort of Tanzanian children,
who were monitored for 4 years in order to determine the immunofibrogenic and
infectious correlates of progressive scarring trachoma. In this cohort baseline, 506
children aged 6–10 years were assessed for clinical signs, infection status and the
expression of 91 genes of interest prior to mass azithromycin administration for trachoma
control. C. trachomatis was detected using droplet digital PCR and gene expression
was measured using quantitative real-time PCR. The prevalence of follicles, papillary
inflammation and scarring were 33.6, 31.6, and 28.5%, respectively. C. trachomatis was
detected in 78/506 (15.4%) individuals, 62/78 of whom also had follicles. C. trachomatis
infection was associated with a strong upregulation of IFNG and IL22, the enrichment
of Th1 and NK cell pathways and Th17 cell-associated cytokines. In individuals with
inflammation in the absence of infection the IFNG/IL22 and NK cell response was
reduced, however, pro-inflammatory, growth and matrix factors remained upregulated
and mucins were downregulated. Our data suggest that, strong IFNG/IL22 responses,
probably related to Th1 and NK cell involvement, is important for clearance of
C. trachomatis and that the residual pro-inflammatory and pro-fibrotic phenotype
that persists after infection might contribute to pathological scarring. Interestingly,
females appear more susceptible to developing papillary inflammation and scarring
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thanmales, even at this young age, despite comparable levels ofC. trachomatis infection.
Females also had increased expression of a number of IFNγ pathway related genes
relative to males, suggesting that overexpression of this pathway in response to infection
might contribute to more severe scarring. Longitudinal investigation of these factors
will reveal their relative contributions to protection from C. trachomatis infection and
development of scarring complications.
Keywords: trachoma, Chlamydia trachomatis, gene expression, mass azithromycin administration, longitudinal
study, active trachoma, conjunctival scarring
INTRODUCTION
Trachoma, a Neglected Tropical Disease caused by the bacterium
Chlamydia trachomatis, remains the leading infectious cause of
blindness worldwide. It is characterized by repeated conjunctival
infection initiated early in childhood, triggering inflammation
(trachomatous inflammation—intense and trachomatous
inflammation—follicular) that drives scarring and trichiasis (in-
turned eyelashes) and eventually blinding corneal opacification
(Hu et al., 2013a; Taylor et al., 2014; Ramadhani et al., 2016a).
The burden of this disease is high; current estimates indicate 200
million people live in trachoma endemic areas in 42 countries
(World Health Organization, 2016). Approximately 1.9 million
people are visually impaired or irreversibly blind from trachoma
(Bourne et al., 2013). To meet this public health challenge, the
WHO-led Global Alliance for the Elimination of Trachoma
recommends the implementation of the SAFE strategy which
tackles the disease at different stages: Surgery to correct trichiasis,
Antibiotics to treat chlamydial infection and Facial cleanliness
and Environmental improvements to suppress transmission of
infection (Taylor et al., 2014).
Our understanding of this disease process is only partial (Hu
et al., 2013a). There are few detailed long-term longitudinal
studies that investigate the risk factors for and pathophysiology
of scarring trachoma (Dawson et al., 1990; West et al., 2001;
Wolle et al., 2009a,b; Burton et al., 2015). These studies
have consistently found incident and progressive scarring to
be strongly associated with clinically apparent conjunctival
inflammation (Ramadhani et al., 2016a). However, only one
study has prospectively examined the relationship between
C. trachomatis infection and the development of incident
scarring in younger people; this found that the detection of
infection and/or severe inflammation on multiple occasions
was associated with increased risk of new scarring (Wolle
et al., 2009b). The relationship between chlamydial infection
and progression of previously established scarring in adults
has been prospectively examined in two longitudinal cohorts;
neither found an association (Burton et al., 2015). This raises
the possibility that progressive scarring may not be entirely
dependent on continual re-exposure to C. trachomatis. It is
possible that repeated chlamydial infection results in long-term
physiological changes in conjunctival tissue responsiveness, such
that other pro-inflammatory factors may stimulate on-going
fibrotic responses (Kechagia et al., 2016). For trachoma control
programmes, this raises the possibility that scarringmay continue
to progress after ocular chlamydial infection has been eliminated
from the population. The implication of this is that services for
managing incident trichiasis may be needed for many years.
Previously, we and others have explored the immunological
correlates of the different stages of trachoma mostly through
cross-sectional studies using a range of methodologies, including
gene expression and protein analysis, immunohistochemistry
and genome wide association studies (Bobo et al., 1996; Burton
et al., 2004, 2011b, 2015; Skwor et al., 2008; Holland et al.,
2010; Natividad et al., 2010; Derrick et al., 2013, 2016a,b; Hu
et al., 2013a, 2016; Roberts et al., 2015). These studies have
shown an increase in pro-inflammatory and matrix factors
(IL1B (interleukin 1 beta), TNF (tumor necrosis factor), S100A7
(psoriasin), IL17A, IFNG (interferon gamma), perforin, IL12,
IL10, CXCL5, CTGF (connective tissue growth factor) andMMP9
(matrix metalloproteinase 9) in individuals with active trachoma
and/or chlamydial infection, indicating the involvement of a
type 1 T helper (Th1) cell response, NK cell cytotoxicity and
potentially Th17 cells. In individuals with trachomatous scarring
and/or trichiasis, factors involved in innate pro-inflammatory
responses and matrix remodeling (IL1B, CXCL5, S100A7, CTGF,
MMP7, andMMP9) were upregulated.
To understand the immunofibrogenic correlates of
progressive conjunctival scarring we conducted a long-term
cohort study. Here we present the baseline findings for a large
panel of factors, to define those to be examined in the prospective
study.
METHODS
Ethics Statement
This study was reviewed and approved by the Tanzanian
National Institute for Medical Research Ethics Committee, the
Kilimanjaro Christian Medical Centre Ethics Committee, and
the London School of Hygiene and Tropical Medicine Ethics
Committee. It adhered to the tenets of the Declaration of
Helsinki.
Study Population
The study was conducted in three adjacent trachoma endemic
villages in Kilimanjaro and Arusha regions, Northern Tanzania.
The villages are relatively remote, geographically neighbors
and have similar patterns of life and traditions. This area is
predominantly inhabited by people of the Maasai tribe. Pastoral
activities are the main occupation. The area is dry for much of the
year, except for the rainy season (February to May). Water supply
is therefore limited, and largely depends on a long-distance
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water pipe scheme from Mount Kilimanjaro. Family units are
organized in Bomas, with living huts arranged in a circle around
a central animal enclosure, which is often characterized by a high
density of flies.
In January 2012, we recruited a cohort of children aged
6–10 years from these villages. The cohort has subsequently
been followed-up every 3 months for 4 years to investigate the
pathogenesis of conjunctival scarring. All children, aged 6–10
years, who were normally resident in one of the three villages,
were eligible for inclusion. We chose this restricted age group as
we considered that they were more likely to show evidence of
incident or progressive conjunctival scarring during the 4 years
of the study. At the outset community meetings were held to
introduce the study. Each household was then visited to meet the
parents or legal guardians of children eligible for enrolment. A
field worker explained the nature of the study in detail in either
Swahili or Maasai language. There was an opportunity to discuss
and ask questions. Finally, if the parent or guardian agreed to
allow the child to be enrolled into the study this was documented
on a consent form in Kiswahili, and witnessed by a third
person.
Clinical Assessments and Sample
Collection
The left eye of each child was examined by an ophthalmic
nurse experienced in grading trachoma. The examinations were
all performed under standardized conditions, using x2.5 loupes
and a bright touch. The conjunctiva was anesthetized with a
drop of preservative-free proxymetacaine hydrochloride 0.5%w/v
(Minims R©, Chauvin Pharmaceuticals Ltd, Surrey, UK). The
eyelid was everted, examined and photographed (Nikon D90
with 105 mm Macro lens). Two conjunctival swab samples
(Dacron polyester, Puritan Medical Products Company, Maine,
USA) were collected for C. trachomatis detection and gene
expression analysis. The swabs were passed across the upper
tarsal conjunctiva four times, with a quarter turn between each
pass. The first swab was placed directly into a tube containing
RNAlater (Thermo Fisher Scientific, Massachusetts, USA) and
the second into a dry tube. The samples were placed into a cool
box. Later the same day the dry swab samples were stored directly
at−80◦C and the RNAlater samples kept at 4–8◦C overnight and
then stored at−80◦C. Air control swabs were collected after every
50 samples by passing a swab 10 cm from a participant’s everted
eye, these were labeled and processed identically to participant
samples.
Clinical signs were graded using the 1981 WHO Detailed
Trachoma Grading System (FPC) (Dawson et al., 1981). This
sub-divides the features into several four-point severity scales:
follicles (F), papillary inflammation (P), and conjunctival
scarring (C). This system corresponds to the WHO Simplified
Trachoma Grading System in the following way: Trachomatous
inflammation-Follicular (TF) is equivalent to F2/F3 and
Trachomatous inflammation-Intense (TI) is equivalent to P3
(Thylefors et al., 1987). For the purpose of this study, we consider
that both P2 and P3 represent clinically significant papillary
inflammation, and refer to this as “TP” (Burton et al., 2015).
We followed the widely used definition of “Clinically Active
Trachoma”: TF and/or TI. The digital photographs were graded
by an ophthalmologist experienced in trachoma assessment,
using the FPC system, supplemented by a previously described
system for fine grading of conjunctival scarring, that quantifies
the extent of the conjunctiva involved (Hu et al., 2011). The
ophthalmologist was masked to the infection status.
Extensive public health education about trachoma was
provided to the community through village level meetings and
during the house-to-house visits, including the importance of
face washing for children and environmental improvements.
Trichiasis surgery was provided free of charge within the
community. Subsequently, all residents of the three villages have
been offered three rounds of annual mass antibiotic treatment
with oral azithromycin (and topical tetracycline ointment for
infants under 6 months and pregnant women), during the course
of the longitudinal study.
C. trachomatis Detection
To detect C. trachomatis, we extracted DNA from swab samples
stored in dry tubes using the PowerSoil DNA Isolation Kit
(Mo Bio Laboratories, California, USA), according to the
manufacturer’s instructions. The cells attached to the swabs were
initially disrupted by bead beating to release their contents.
C. trachomatis DNA was detected using a previously described
droplet digital PCR assay (Roberts et al., 2013). All samples
were tested for the C. trachomatis plasmid and the human gene
RPP30. Samples in which C. trachomatis plasmid was detected
were retested for C. trachomatis omcB (a single-copy gene on
the chlamydial chromosome). Five microliters of template DNA
was added per reaction. PCR reaction conditions were as follows:
95◦C for 10 min, then 40 cycles of 95◦C for 10 s and 60◦C for
30 s and finally 98◦C for 12 min. Droplets were then examined
for fluorescence on a QX100 Droplet Reader (Bio-Rad, UK),
providing a quantitative result.
Human Gene Expression Analysis
Total RNA was extracted from the swab stored in RNALater
using a DNA/RNA Purification Kit (Norgen Biotek Corp,
Canada), following the manufacturer’s instructions. RNA was
reverse transcribed using the SuperScript R© VILO R© cDNA
Synthesis Kit (Life Technologies). Quantitative real-time PCR
was performed to measure the relative abundance of a panel of
human transcripts, using the TaqMan R© Microfluidic 384-well
Low-Density Array (TLDA) (Life Technologies) on a ViiA7 real-
time PCR instrument (Thermo Fisher Scientific, Massachusetts,
USA). These cards have separate channels for eight samples,
each containing 48 wells, pre-printed with the assay primers and
probes. We used two different TLDA designs and measured the
expression of 91 different genes of interest for each sample. The
selected genes are listed in Table 5. We measured expression of
three different reference genes: HPRT1, GAPDH, and RPLP0.
HPRT1 was selected as the most suitable for normalization as it
was expressed at a relatively similar level to the majority of other
transcripts of interest, whereas GAPDH and RPLP0 were very
highly expressed. The choice of transcripts tested was informed
by previous gene expression studies including transcriptome
analysis experiments on samples from The Gambia, Ethiopia
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and Tanzania and by a genome-wide association study from The
Gambia (Holland et al., 2010; Natividad et al., 2010; Burton et al.,
2011b,c, 2015; Roberts et al., 2015).
Statistical Analysis
Data were managed in Access and transferred to STATA
v14 for analysis. The ophthalmologist’s grading of the digital
photographs was used for analysis. The ddPCR results were
initially exported to R for analysis; the critical cut-off value for
designating a positive result for each target was 0.2 plasmid
copies/µl of eluted DNA, 0.2 omcB copies/µl and >0.3 RPP30
copies/µl. Samples were designated C. trachomatis positive if
plasmid and human RPP30 were detected.
The associations between each of the clinical signs (follicular
inflammation, papillary inflammation and scarring) and
C. trachomatis infection were assessed using univariable
logistic regression with infection as the outcome variable. The
associations between scarring and each of the other clinical
signs, infection, sex and age were investigated with logistic
regression, using presence of scarring as the outcome variable.
Initially, univariable logistic regression was performed using
each exposure in turn, and then a multivariable analysis was
performed in order to provide an unbiased estimate of the
association between exposure and outcome adjusting for all
clinical features.
The gene expression data were normalized relative to the
expression of HPRT1 in the same sample, to adjust for variable
concentrations of cDNA. This was done by the 1CT method.
Distributions of 1CT values were plotted to assess them for
normality. Fold change differences in gene expression between
different phenotypic groups (Infection, follicular inflammation,
papillary inflammation and scarring), vs. individuals without
those clinical signs or infection, were calculated using the
11CT method. Linear regression was used to compare the two
groups in each comparison, with 1CT values as the dependent
variable and each phenotype group in turn as the independent
variable, adjusting for age and sex. To take account of multiple
comparisons we used a false discovery rate (FDR) of 5%
(Benjamini and Hochberg, 1995). The linear regression analyses
were repeated, but rather than taking the four phenotypic
groups individually, they were all included as exposures in a
multivariable model with age and sex, providing estimates of the
fold-changes associated with each phenotype.
A heatmap of 1CT values for each gene of each participant
was produced, to indicate visually whether the expression of
individual genes was consistently of higher or lower expression
in groups of individuals with clinically active Trachoma (TF
and/or TI) and/or infection. A principal component analysis
(PCA) was performed on the gene expression data and clinical
disease and infection status were overlaid on plots in order
to visually indicate any associations between the first two
components and infection, active trachoma and scarring. These
associations were tested formally using a logistic regression
analysis, with the principal components as the exposure
variables. For the heatmap and PCA, only individuals with
complete expression data could be included. Therefore, so
as not to lose too many individuals, any target with >5%
of observations missing was excluded from these analyses,
as well as the lasso regression and co-expression analyses
described below. Any individuals with missing observations
on the remaining targets were excluded from these analyses
also.
For each of infection, active trachoma and scarring, a
multivariable logistic regression was performed using this subset
of gene expression levels as exposure variables, with the aim of
retaining those expressions most strongly associated with the
outcome of interest, adjusting for all other expression levels.
Due to the large number of exposure variables, a penalized
logistic regression was performed using the lasso technique
(Tibshirani, 1997). The list of genes most strongly associated with
each outcome was entered into ConsensusPathDB (http://cpdb.
molgen.mpg.de/) gene set over-representation analysis, with all
genes tested entered as background. Enriched pathway-based sets
with a minimum overlap between pathway and input gene list of
two and a p< 0.05 were identified.
A network graph based on the specimen-to-specimen Pearson
correlation was generated using miru (https://kajeka.com/miru).
The overall expression correlation matrix and graph were
constructed from the raw cycle threshold expression values.
The filtered dataset including only individuals and genes
with complete expression data was used. Pearson correlation
coefficients (r) ≥0.85 were retained and used as cut-offs in
network construction. Nodes in the graph are individual mRNA
transcripts linked by an edge if r was ≥0.85. The graph was
then clustered using a Markov Clustering algorithm with an
inflation value of 2.2. The partitioned clusters of expression
contain sets of transcripts that exhibit a very high degree
of co-expression across the sample set. The co-expression
clusters or modules were then investigated for enrichment
at the pathway level using ConsensusPathDB as described
above, using all genes tested as background. A single value
for each cluster of each individual was defined using the first
principal component and this value was used to investigate
differential expression associated with disease and infection
phenotypes.
RESULTS
Study Participants
A total of 506 children between the ages of 6 and 10 years
were recruited and examined. Their demographic and clinical
characteristics are described in Table 1. There were almost equal
numbers of male and female children, with a mean age of 7.5
years. Most (97.4%) of the children were of the Maasai ethnic
group.
Active Trachoma
Trachomatous inflammation-Follicular (TF, F2/F3) was present in
170 (33.6%) children (Table 1). However, a further 135 (26.7%)
had evidence of mild follicular conjunctivitis (F1). Significant
conjunctival papillary inflammation (TP, P2/P3) was observed in
160 (31.7%) children, of which 64 (12.7%) had intense papillary
inflammation (TI, P3).
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TABLE 1 | Demographic characteristics, clinical signs and C. trachomatis
infection status.
Category n/506 (%)
Sex (Male) 251 (49.6%)
ETHNIC GROUP
Maasai 493 (97.4%)
Chaga 7 (1.4%)
Sonjo 4 (0.8%)
Pare 2 (0.4%)
Age in years (mean and range) 7.5 (6–10)
SIMPLIFIED WHO GRADING
TF 170 (33.6%)
TI 64 (12.7%)
TS 144 (28.5%)
DETAILED “FPC” WHO GRADING
Follicles
F0 201 (39.7%)
F1 135 (26.7%)
F2 81 (16.0%)
F3 89 (17.6%)
Papillae
P0 180 (35.6%)
P1 166 (32.8%)
P2 96 (19.0%)
P3 64 (12.7%)
Scarring
C0 362 (71.5%)
C1 120 (23.7%)
C2 21 (4.2%)
C3 3 (0.6%)
DETAILED TARSAL CONJUNCTIVA SCARRING GRADING SYSTEM
S0 362 (71.5%)
S1a 71 (14.0%)
S1b 28 (5.5%)
S1c 26 (5.1%)
S2 19 (3.8%)
S3 0 –
C. trachomatis PLASMID DETECTED
No 428 (84.6%)
Yes 78 (15.4%)
The clinical signs were determined by grading of photographs.
C. trachomatis Infection and Active
Trachoma
C. trachomatis plasmid was detected by ddPCR in 78 (15.4%)
individuals. There was a strong association between the presence
of TF and the detection of C. trachomatis plasmid; 62/78 (79.5%)
of C. trachomatis positive individuals had TF (Table 2). Of the 16
infected children who did not have TF, 11 (68.8%) had signs of
mild follicular conjunctivitis (F1). However, only 62/170 (36.5%)
individuals with TF had detectable infection. There was a similar
strong association between the presence of TP and chlamydial
infection (Table 2).
Infection load and the concentration of RPP30 endogenous
control DNA were quantified. The concentration of plasmid
DNA ranged from 0.22 to 3023 copies/µl, omcB ranged from 0.2
to 742 copies/µl and RPP30 ranged from 0.32 to 1,081 copies/µl
of eluted DNA. All samples had detectable RPP30. There was
a marked positive trend in both the proportion infected and
the load of infection with increasing F-Score and increasing P-
Score (Table 2). There was a consistent ratio of plasmid to omcB
copies/µl: geometric mean ratio of 4.57 to 1 (95% CI 3.91–5.34)
and a median of 4.79 to 1 (95%CI 4.01–5.21). The correlation
between plasmid and omcB copies/µl is illustrated in Figure 1.
The ratio did not vary with either the follicular or papillary
clinical severity scores (data not shown).
Conjunctival Scarring
Conjunctival scarring was relatively frequent, being found in
144 (28.5%) individuals; this was mostly mild scarring (Table 1).
There was a significant association between the detection of
C. trachomatis and scarring [p = 0.002, OR = 2.23 (95%CI
1.4–3.7)]. The load of infection also increased with scarring
severity (Table 2). There were univariate associations between
conjunctival scarring and TF, TP (P2/P3), C. trachomatis
detection and female sex (Table 3). However, in a multivariable
model only TP, female sex and age were independently associated
with scarring.
There was strong evidence (p = 0.0047) that even at this
young age females are proportionately more likely to have signs
of established scarring than males (Table 4). Similarly, there was
some evidence (p = 0.048) that females had slightly increased
odds of TP. No evidence was found of an association between sex
and the odds of TF or chlamydial infection (p = 0.12 and 0.25,
respectively) (Table 4).
Conjunctival Gene Expression
The expression of 91 target genes was measured relative to
that of HPRT1. Out of the 506 participants, samples from
12 individuals failed the qPCR for all target genes, leaving
494 individuals for gene expression analysis. The number of
participant samples with detectable expression for each target
is shown in Supplementary Table 1 (N). Multivariable linear
regression analysis was performed using data for all 91 genes
from 494 individuals.
Four sets of comparisons were performed: (1) infected v non-
infected, (2) TF v no TF, (3) TP v no TP, and (4) TS v no TS.
The relative Fold Change (FC) between these paired groups,
calculated by the11CT method, are presented in Supplementary
Table 1 along with the p-values for the linear regression (adjusted
for age and sex) for each comparison.
As clinical signs and infection may be highly correlated
in their association with the expression of specific targets we
tested for independent associations with each target’s expression
usingmultivariable linear regressionmodels,Table 5. More genes
were significantly differentially expressed in individuals with
C. trachomatis infection (55/91) relative to individuals with
TP (33/91), TF (11/91), and TS (17/91) in these multivariable
models (P < 0.05). C. trachomatis Infection was associated
with increased expression of multiple cytokines and chemokines
(CCL2, CXCL13, CCL18, CSF2, FOXP3, IFNG, IDO1, IL1B,
IL6, IL8, IL10, IL12B, IL17A, IL19, IL21, IL22, IL23A), cell
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TABLE 2 | C. trachomatis plasmid detection and clinical signs; both the simplified and detailed WHO “FPC” grading system.
C. trachomatis plasmid OR (95%CI) p-value Geometric mean
No (%) Yes (%) Plasmid omcB
FOLLICULAR INFLAMMATION
No TF 320 (95.2%) 16 (4.8%) 1 – – 2.99 0.86
TF 108 (63.5) 62 (36.5%) 11.48 (6.4–20.7) 5.95E-16 16.27 4.26
FPC FOLLICLE SCORE
F0 196 (97.5%) 5 (2.5%) 1 – – 3.41 1.04
F1 124 (91.9%) 11 (8.2%) 3.48 (1.2–10.2) 0.024 2.82 0.81
F2 65 (80.3%) 16 (19.8%) 9.65 (3.4–27.4) 2.03E-05 20.05 4.17
F3 43 (48.3%) 46 (51.7%) 41.93 (15.7–111) 7.97E-14 15.13 4.29
PAPILLARY INFLAMMATION
No TP 323 (93.4%) 23 (6.7%) 1 – – 4.11 1.23
TP (P2/P3) 105 (65.6%) 55 (34.4%) 7.36 (4.3–12.5) 2.45E-13 17.67 4.64
FPC PAPILLARY SCORE
P0 173 (96.1%) 7 (3.9%) 1 – – 2.53 0.72
P1 150 (90.4%) 16 (9.6%) 2.63 (1.1–6.6) 0.038 5.09 1.41
P2 73 (76%) 23 (23.9%) 7.79 (3.2–18.9) 6.07E-06 13.47 2.65
P3 32 (50%) 32 (50.0%) 24.71 (10.0–60.8) 2.95E-12 21.47 6.99
SCARRING
No 318 (87.9%) 44 (12.2%) 1 – – 9.67 2.59
Yes 110 (76.4) 34 (23.6%) 2.23 (1.4–3.7) 0.002 14.38 4.35
FPC SCARRING SCORE
C0 318 (87.9%) 44 (12.2%) 1 – – 9.67 2.59
C1 89 (74.2%) 31 (25.8%) 2.52 (1.5–4.2) 0.0005 12.33 4.08
C2 18 (85.7%) 3 (14.3%) 1.20 (0.3–4.3) 0.77 70.24 7.85
C3 3 (100%) 0 – – –
DETAILED SCARRING SCORE
S0 318 (87.9%) 44 (12.2%) 1 – – 9.67 2.59
S1a 56 (78.9%) 15 (21.1%) 1.94 (1.0–3.7) 0.047 7.98 3.44
S1b 21 (75.0%) 7 (25.0%) 2.41 (1.0–6.0) 0.059 15.24 4.26
S1c 17 (65.4%) 9 (34.6%) 3.83 (1.6–9.1) 0.0024 21.61 5.32
S2 16 (84.2%) 3 (15.8%) 1.36 (0.4–4.8) 0.64 70.24 7.85
S3 0 – 0 – – –
P-values were calculated by Pearson χ2. TP is equivalent to P2 or P3 of the FPC papillary score.
cycle components (CDC25C, TTK, TYMS), matrix modifiers
(MMP7, MMP9, MMP12, TGFB1), NK cell markers (CD247,
NCR1, NCAM1) and intracellular signaling molecules/regulators
(CD274, IKZF1, RHOH, SAMSN1, SERPINB3, SERPINB4,
STAT1, STAT4, SOCS1, TBX21), Table 5. Infection was associated
with particularly marked increases in expression of IFNG (FC:
7.12, p-value: 1.32E-42) and IL22 (FC: 6.49, p-value: 1.6E-23).
There was reduced expression of several factors includingmucins
(MUC1, MUC4, MUC5AC, MUC7) and SPARCL1.
Clinical signs of active trachoma were associated with
increased expression of multiple cytokines, chemokines,
antimicrobial peptides, matrix modifiers, following a similar
pattern to infection (Table 5). TP was associated with more
substantial increases in a wider range of factors than TF (Table 5):
antimicrobial peptides (DEFB4A, S100A7), cytokine/chemokines
(CXCL5, CXCL13, CCL18, CCL2, IL1B, IL8, IL10, IL17A, IL19,
IL23A, PTGS2), matrix modifiers (MMP7, MMP9, MMP12)
and intracellular signaling molecules/regulators (CD274,
SAMSN1, SERPINB3, SERPINB4, SOCS3). Several cytokines
and chemokines (CCL18, CXCL13, IL19, and S100A7) had a FC
>2 in children with TP. Conjunctival scarring was associated
with modestly increased expression (>1.2 FC) and borderline
significance of several chemokines and cytokines (CCL2,
CCL20, CXCL5, CSF3, IL1B, IL8, IL10, IL21, IL33, FGF2) in the
multivariable linear regression models (Table 5). SPARCL1 was
significantly downregulated in TF and TP but not TS.
Only 108 individuals had detectable gene expression for all 91
targets, so in order to retain a reasonable number of individuals in
the PCA and lasso analyses, which require complete records for
all individuals, targets which were missing >5% of observations
were excluded. This resulted in the exclusion of eight transcripts
(USP6, IL13, CTNND2, FGF2, SERPINB4, IL22, PREX2v1,
PREX2v2) for which there was no detectable expression in >5%
individuals. In individuals with detectable expression of these
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FIGURE 1 | The relationship between paired measures of copies of Chlamydia
trachomatis plasmid/µl vs. omcB/µl in the same sample. Correlation
R-squared = 0.989.
TABLE 3 | Univariable and multivariable associations between conjunctival
scarring and other clinical features, C. trachomatis infection, sex and age.
Variable OR 95% CI p-value
UNIVARIABLE ANALYSIS
TF 2.28 (1.53–3.40) 5.20E-05
TP (P2/P3) 2.98 (1.99–4.47) 1.22E-07
Plasmid 2.23 (1.36–3.67) 0.002
Sex (Female) 1.76 (1.19–2.61) 0.005
Age 1.06 (0.97–1.17) 0.217
MULTIVARIABLE LOGISTIC REGRESSION
TF 1.39 (0.79–2.44) 0.251
TP (P2/P3) 2.60 (1.52–4.44) 4.83E-04
Plasmid 1.33 (0.75–2.37) 0.326
Sex (Female) 1.63 (1.08–2.45) 0.019
Age 1.16 (1.05–1.29) 0.005
eight targets, raw CT values were generally very high (CT >
33). These eight targets were excluded from the heatmap, PCA,
lasso regression and co-expression network analyses, retaining
a complete expression dataset for 83 genes. Among the 494
individuals, 36 were excluded as they hadmissing data among the
83 included targets, resulting in a final dataset of 458 individuals
and 83 genes. Excluding further genes offered minimal gains in
sample size. A heatmap of 1CT values separated by clinical and
infection phenotype is presented in Figure 2. Infected individuals
with or without active trachoma had a visibly distinct pattern
of gene expression, whereas the 1CT values of normal healthy
controls and individuals with active trachoma in the absence of
infection appeared more similar overall.
PCA analysis was performed for 458 individuals that had
complete gene expression data for 83 targets and active
trachoma/infection and scarring status were overlaid on plots,
Supplementary Figures 1A,B. Principal component 1 (PC1) was
strongly associated with infection and active trachoma; for a
one unit increase in PC1 there was an estimated 35% decrease
in the odds of infection (95% CI 27–41%, p < 0.001) and an
estimated 23% decrease in the odds of active trachoma (95% CI
9–28%, p < 0.001). PC1 loadings showed that as genes in the
chemokines/cytokines and regulator/signaling pathways groups
were up-regulated, PC1 became smaller, suggesting that the
odds of infection/active trachoma was greater among individuals
where these genes are up-regulated. The expression of mucins,
CDH1, SPARCL1, and S100A4 showed the reverse relationship,
as when these genes were down-regulated the PC1 was smaller.
Principal component 2 (PC2) was associated with increased odds
of active trachoma alone, with a unit increase in PC2 being
associated with an estimated 15% increase in the odds (95% CI 7–
24%, p< 0.001), however there was no evidence of an association
between PC2 and infection. There was evidence of a weaker
association between PC1 and scarring, with an estimated 10%
decrease in the odds of scarring (95% CI 6–14%, p < 0.001) per
unit increase in PC1, Supplementary Figure 1B. There was no
evidence of an association between scarring and PC2.
Three lasso logistic regressions were performed, first using
infection (with or without active disease) as the outcome and the
83 targets, age and sex of 458 individuals as exposures. Then,
excluding all infected individuals, active trachoma (uninfected
only) was used as the outcome against uninfected individuals
without active trachoma and the same 83 targets, age and
sex as the exposures of interest. Finally, the regression was
performed using scarring as the outcome and the same set of
exposures in all 458 individuals. The transcripts most strongly
associated with each of the three outcomes, and biological
pathways with members that were over-represented in each
relative to the background (83 targets) are listed in Table 6.
Genes most strongly associated with infection were associated
with Th1 cell development and NK cell pathways, whilst
genes most associated with active trachoma in the absence of
C. trachomatis infection were enriched for members of leukocyte
transendothelial migration, TNF receptor, MMP activation,
collagen formation and collagen fibrils assembly pathways. Genes
most strongly associated with the TS phenotype were enriched for
members of immunoregulatory interactions between lymphoid
and non-lymphoid cells.
Networks of co-expression, independent of differential
expression, were explored in the complete expression data of
83 transcripts and 458 individuals using Miru. The undirected
graph contained 51 nodes connected by 121 edges. Markov
clustering partitioned the network into 5 separate clusters of
co-expressed genes that accounted for 38/51 (74.5%) of the
transcripts in the original network. Cluster 1 contained 11 co-
expressed transcripts, cluster 2 contained 10 transcripts, there
were 6 transcripts in each of cluster 3 and 4, and 5 transcripts
in cluster 5 (Supplementary Table 2A), the remaining nodes
were not connected in the graph. The most connected gene
transcript or hub in each module was MyD88/REL (cluster 1),
IKZF1/VIM (cluster 2), STAT1 (cluster 3), SRGN (cluster 4), and
IL10/IL17A/IL21 (cluster 5).
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TABLE 4 | The relationship between sex and (i) clinical signs, (ii) Chlamydia trachomatis infection and (iii) infection load.
Male (%) Female (%) OR (95% CI) p-value
FOLLICULAR INFLAMMATION
No TF 175 (69.7%) 161 (63.1%) 1 – –
TF 76 (30.3%) 94 (36.9%) 1.34 (0.9–1.9) 0.12
PAPILLARY INFLAMMATION
No TP 182 (72.5%) 164 (64.3%) 1 – –
TP (P2/P3) 69 (27.5%) 91 (35.7%) 1.46 (1.0–2.1) 0.0479
SCARRING
No TS 194 (77.3%) 168 (65.9%) 1 – –
TS 57 (22.7%) 87 (34.1%) 1.76 (1.2–2.6) 0.0047
INFECTION
No 217 (86.5%) 211 (82.6%) 1 – –
Plasmid 34 (13.6%) 44 (17.2%) 1.33 (0.8–2.2) 0.25
GEOMETRIC MEAN AMONG THOSE WITH INFECTION
Plasmid 9.45 (4.6–19.3) 13.37 (7.5–23.7) 0.44α
omcB 2.93 (1.5–5.8) 3.50 (2.1–5.9) 0.67α
αDifferences between chlamydial load geometric means in males and females were calculated using a t-test.
Pathway enrichment analysis was performed for each cluster
relative to the background of 83 transcripts (Supplementary Table
2B).1CT values for the transcripts in each cluster were collapsed
into a single value for each of the 458 individuals, represented
by the first principal component. Multivariable linear regression
was then performed for each cluster, using the first principal
component as the outcome variable and TF, TP, TS, infection,
age, and sex as independent variables (Supplementary Table 2C).
Cluster 1 was enriched for cell cycle and apoptosis pathways,
however the combined expression value was not differentially
expressed in any condition. Cluster 2 was significantly associated
with infection and TF and was marginally enriched for the
retinoblastoma pathway. Cluster 3 was highly enriched for Th1/2
cell differentiation, IFNγ, IL-12, CD8, and NK cell signaling
pathways and was strongly associated with infection and age and
marginally associated with sex, but interestingly not with TP or
TF. Conversely, cluster 4 was enriched for TNF, inflammasome,
TLR and NFkB signaling pathways and was associated with TP,
TS, and age but not infection. Cluster 5 was enriched for the
allograft rejection pathway and was associated with infection, TP,
TS and age.
DISCUSSION
Clinical Disease and C. trachomatis
Infection
In this study, conducted in communities prior to azithromycin
MDA, there was a relatively high TF (34%) and moderate
C. trachomatis (15.4%) prevalence in 6–10 year olds. There was
a strong relationship between infection and clinical signs. The
largemajority (79.5%) of individuals withC. trachomatis detected
by ddPCR had TF (F2/F3). Moreover, most individuals (68.8%)
with detectable chlamydial infection but without TF had a mild
follicular conjunctivitis (F1). There were few cases of infection in
the absence of clinical signs. This is consistent with earlier studies
which found a stronger correlation as the underlying prevalence
of infection increased (Ramadhani et al., 2016b). However, in
common with many other studies reporting the relationship
between disease and infection, a minority (36%) of individuals
with TF had detectable infection, probably due to the shorter
duration of infection episodes relative to disease (Grassly et al.,
2008; Burton et al., 2011a,c; Lee et al., 2014). With increasing
severity of both TF and TP scores, there was an increasing
proportion with infection and increasing loads of infection.
Consistent with earlier studies, increasing load appeared to be
more closely related to increasing TP rather than TF (Burton
et al., 2003; Solomon et al., 2003; Michel et al., 2011; Derrick et al.,
2016a).
In the present cross-sectional study conjunctival scarring
was associated with TP, female sex and increasing age but not
C. trachomatis infection, which is consistent with several earlier
cohort studies (Dawson et al., 1990; West et al., 2001; Wolle et al.,
2009b; Burton et al., 2015; Hu et al., 2016). However, longitudinal
data supporting an association between TF or C. trachomatis
infection and progressive scarring are limited (Ramadhani et al.,
2016a). We found females had more TP and TS than males,
whereas C. trachomatis infection and TF prevalence were not
significantly different between the sexes (Table 4). This might
suggest that there are additional determinants of TP and TS
development beyond the initial C. trachomatis infection. It
is generally believed that the difference in the proportion of
males and females developing scarring sequelae of trachoma
is attributable to a greater life-time exposure to repeated
C. trachomatis infection among females (Taylor et al., 2014).
While that may well be the case, the data from this study
also suggest that even at a relatively young age, females appear
more susceptible to developing TP and TS than males, despite
comparable levels of C. trachomatis infection. This finding
is consistent with the observation that in general, females
generate stronger immune responses than males, making them
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TABLE 5 | Multivariable linear regression models for conjunctival gene expression in the presence of clinical signs, C. trachomatis plasmid, female sex and age.
Target TF TP TS Plasmid Sex (female)α Ageβ
FC p-value FC p-value FC p-value FC p-value FC p-value FC p-value
ANTIMICROBIAL PEPTIDES
Defensin, beta 4B,defensin, beta 4A
(DEFB4A)
0.77 0.0919 2.08 2.37E-06 1.12 0.3844 1.28 0.1459 1.37 0.0044 0.92 0.0022
Psoriasin-1 (S100A7) 1.40 0.1605 2.86 8.94E-06 1.25 0.2520 1.77 0.0279 1.36 0.0672 0.88 0.0039
CELL CYCLE
CD53 molecule (CD53) 0.98 0.7932 1.19 0.0033 1.08 0.1263 1.15 0.0340 1.03 0.4334 0.98 0.1419
M-phase inducer phosphatase 3
(CDC25C)
1.17 0.0490 1.08 0.3434 1.04 0.5710 1.36 0.0005 1.02 0.7103 0.99 0.4182
Cyclin-dependent kinase 13 (CDK13) 1.00 0.9318 0.88 0.0037 1.02 0.6393 0.92 0.0908 1.00 0.8874 1.01 0.1454
Catenin (cadherin-associated
protein), delta 2 (CTNND2)
1.08 0.7376 0.81 0.3716 1.02 0.9196 0.79 0.3411 0.90 0.5413 1.06 0.1744
Sun Domain Family, Member 6
(NSUN6)
0.94 0.0874 0.98 0.5339 1.04 0.2220 1.01 0.8099 0.95 0.0359 1.01 0.1160
Phytanoyl-coa 2-hydroxylase (PHYH) 0.92 0.0678 0.95 0.2639 1.01 0.8297 0.85 0.0010 0.97 0.4291 1.02 0.0196
Tumor protein p53 (TP53) 1.01 0.7419 0.85 0.0001 1.03 0.3965 1.01 0.8485 0.97 0.3148 1.01 0.0460
TTK protein kinase (TTK) 1.16 0.0209 1.11 0.0933 1.10 0.0719 1.31 0.0002 0.98 0.7333 0.99 0.4067
Thymidylate synthetase (TYMS) 1.11 0.0590 1.16 0.0050 1.00 0.9654 1.62 6.38E-15 1.05 0.2448 0.99 0.1936
CYTOKINES/CHEMOKINES
Chemokine ligand 18 (CCL18) 1.00 0.9903 3.03 6.14E-10 0.94 0.6534 1.99 0.0004 0.97 0.8422 0.89 0.0006
Chemokine ligand 2 (CCL2) 0.95 0.7092 1.63 0.0008 1.39 0.0060 3.36 1.45E-13 1.13 0.2284 0.87 1.06E-07
Chemokine ligand 20 (CCL20) 1.45 0.0005 1.04 0.7406 1.33 0.0011 1.23 0.0735 0.97 0.7140 0.95 0.0035
Chemokine receptor 6 (CCR6) 1.53 0.0011 0.83 0.1466 1.11 0.3398 1.10 0.4912 1.12 0.2129 0.96 0.1173
Colony stimulating factor 2 (CSF2) 1.19 0.0798 1.05 0.6564 1.13 0.1416 2.45 2.83E-15 1.14 0.0690 0.99 0.5702
Colony stimulating factor 3 (CSF3) 0.97 0.8494 1.40 0.0206 1.52 0.0005 0.85 0.3008 0.99 0.8901 0.91 0.0008
Chemokine ligand 13 (CXCL13) 1.41 0.0321 2.01 1.22E-05 1.14 0.3140 2.11 2.29E-05 1.23 0.0733 0.87 3.46E-06
Chemokine ligand 5 (CXCL5) 1.11 0.4860 1.82 0.0001 1.60 0.0001 0.82 0.2278 0.88 0.2371 0.88 6.49E-06
Forkhead box P3 (FOXP3) 1.02 0.7750 1.02 0.7818 0.91 0.0840 1.25 0.0014 0.95 0.2135 1.00 0.9477
Indoleamine 2,3-dioxygenase 1
(IDO1)
1.17 0.1491 1.28 0.0187 1.24 0.0139 1.73 3.53E-06 1.34 0.0001 0.89 1.05E-08
Interferon gamma(IFNG) 1.36 0.0109 1.09 0.4791 1.12 0.2396 7.12 1.32E-42 1.29 0.0025 0.91 2.97E-05
Interleukin 10 (IL10) 1.13 0.2184 1.49 3.48E-05 1.22 0.0141 1.78 7.86E-08 1.09 0.2106 0.94 0.0004
Interleukin 12 beta (IL12B) 1.15 0.2315 1.19 0.1340 1.07 0.4853 3.42 3.90E-21 1.23 0.0106 0.97 0.2047
Interleukin 13 (IL13) 1.63 0.1091 0.66 0.1804 0.80 0.2701 1.38 0.2585 1.03 0.8545 1.07 0.1290
Interleukin 17A (IL17A) 1.16 0.2561 1.65 0.0001 1.19 0.0928 2.34 1.85E-09 1.18 0.0688 0.90 3.56E-06
Interleukin 19 (IL19) 0.96 0.7566 2.63 5.69E-11 1.16 0.2150 2.11 3.75E-06 1.43 0.0006 0.88 6.69E-07
Interleukin 1 beta(IL1B) 0.97 0.8261 1.72 5.46E-06 1.36 0.0021 1.55 0.0009 1.04 0.6251 0.92 0.0002
Interleukin 21 (IL21) 1.68 0.0003 1.36 0.0290 1.34 0.0132 3.10 1.69E-12 1.16 0.1432 0.90 0.0001
Interleukin 22 (IL22) 1.14 0.4452 1.26 0.1548 1.31 0.0511 6.49 1.60E-23 1.22 0.0973 0.93 0.0302
Interleukin 23A (IL23A) 0.98 0.8604 1.70 3.81E-08 1.10 0.2287 1.87 3.62E-09 0.99 0.8875 0.93 3.13E-05
Interleukin 33 (IL33) 0.96 0.6351 0.92 0.3465 1.28 0.0009 1.27 0.0164 0.96 0.5468 1.03 0.0472
Interleukin 6 (IL6) 0.92 0.5490 1.27 0.0721 1.27 0.0303 1.80 0.0001 0.92 0.3965 0.94 0.0057
Interleukin 8 (IL8) 0.87 0.1443 1.43 0.0001 1.24 0.0041 1.32 0.0063 1.00 0.9975 0.97 0.0751
Prostaglandin-endoperoxide synthase
2 (PTGS2)
0.90 0.3527 1.45 0.0009 1.26 0.0116 1.18 0.1781 0.98 0.7886 0.97 0.0978
Tumor necrosis factor (TNF ) 1.39 0.0040 0.93 0.4934 1.16 0.1187 1.30 0.0383 1.15 0.0965 1.00 0.8808
EMT MARKERS
Alpha smooth muscle actin (ACTA2) 1.10 0.1559 0.83 0.0039 1.14 0.0144 1.29 0.0004 1.04 0.3549 0.99 0.4144
Epithelial cadherin (CDH1) 0.94 0.2482 0.93 0.1746 1.05 0.2799 0.78 4.22E-05 0.99 0.7167 1.00 0.9175
Cadherin 1, type 1, E-cadherin
(epithelial) (CDH1)
0.95 0.3727 0.92 0.1964 1.04 0.4101 0.73 3.06E-06 0.99 0.8120 1.01 0.5096
(Continued)
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TABLE 5 | Continued
Target TF TP TS Plasmid Sex (female)α Ageβ
FC p-value FC p-value FC p-value FC p-value FC p-value FC p-value
Neuronal cadherin (CDH2) 0.98 0.8576 0.71 0.0066 1.18 0.1088 1.11 0.4339 1.00 0.9960 1.04 0.0558
S100 calcium binding protein A4
(S100A4)
0.88 0.0691 0.71 1.83E-06 1.15 0.0213 0.47 1.99E-20 0.90 0.0393 1.03 0.0093
Vimentin (VIM) 1.02 0.6112 1.04 0.4486 1.04 0.2589 1.51 8.85E-15 1.01 0.7266 1.01 0.3843
MATRIX MODIFIERS
Connective tissue growth factor
(CTGF-1)
0.98 0.8349 0.81 0.0191 0.98 0.7534 1.20 0.0721 0.79 0.0003 1.02 0.2769
Connective tissue growth factor
(CTGF-2)
0.89 0.2310 0.85 0.0721 0.91 0.2245 1.21 0.0675 0.82 0.0036 1.03 0.0828
Fibroblast growth factor 2 (basic)
(FGF2)
0.86 0.3151 1.11 0.4830 1.43 0.0032 1.48 0.0124 0.87 0.1988 1.01 0.7147
Matrix metallopeptidase 12 (MMP12) 1.31 0.0246 1.48 0.0010 1.26 0.0188 2.00 1.84E-07 1.11 0.2136 0.92 0.0002
Matrix metallopeptidase 7 (MMP7) 0.94 0.5657 1.41 0.0024 1.04 0.7042 0.38 1.63E-14 0.93 0.3375 0.96 0.0488
Matrix metallopeptidase 9 (MMP9) 1.37 0.0048 1.43 0.0012 1.20 0.0519 1.77 3.45E-06 0.98 0.8380 0.96 0.0371
Platelet-derived growth factor beta
polypeptide (PDGFB)
1.00 0.9393 1.08 0.1904 1.16 0.0043 1.43 1.55E-07 1.06 0.1638 0.96 0.0002
SPARC-like 1 (hevin) (SPARCL1) 0.53 0.0048 0.39 3.20E-05 0.85 0.3842 0.46 0.0020 0.75 0.0794 1.20 1.29E-05
Transforming growth factor, beta 1
(TGFβ1)
1.02 0.6999 0.99 0.7693 1.08 0.0491 1.23 0.0001 0.99 0.6965 0.98 0.0305
Transforming growth factor, beta 2
(TGFβ2)
0.97 0.7251 0.96 0.6469 1.08 0.3172 0.91 0.3438 0.92 0.2258 1.01 0.6926
RESPONSE TO MICROBIOTA
Arachidonate 5-lipoxygenase (ALOX5) 0.88 0.0111 0.97 0.4844 1.05 0.2353 0.67 1.78E-13 0.97 0.4387 1.01 0.2310
B-cell CLL/lymphoma 2 (BCL2) 1.00 0.9769 0.94 0.1509 1.09 0.0239 1.13 0.0212 0.97 0.4448 1.00 0.8130
CD40 molecule, TNF receptor
superfamily member 5 (CD40)
0.98 0.6989 0.98 0.7901 1.06 0.2693 1.25 0.0009 1.06 0.1592 1.00 0.8334
Dual oxidase 2 (DUOX2) 0.92 0.3364 1.38 0.0004 1.09 0.2734 1.19 0.0852 1.20 0.0047 0.94 0.0001
V-rel avian reticuloendotheliosis viral
oncogene homolog (REL)
0.96 0.3595 1.08 0.0911 1.05 0.1697 1.03 0.5774 1.05 0.1108 1.00 0.6653
Tumor necrosis factor receptor
superfamily, member 1A (TNFRSF1A)
0.87 0.1556 0.99 0.9463 1.07 0.3766 0.81 0.0448 0.96 0.5130 1.02 0.3991
Tumor necrosis factor receptor
superfamily, member 1B (TNFRSF1B)
0.89 0.1026 1.18 0.0164 1.10 0.0956 1.02 0.8439 0.96 0.4386 1.00 0.7988
MUCINS
Mucin 1, cell surface associated
(MUC1)
0.92 0.1555 1.04 0.4586 1.03 0.4947 0.82 0.0013 1.00 0.9901 1.00 0.8866
Mucin 4, cell surface associated
(MUC4)
0.93 0.3097 1.15 0.0472 1.06 0.3140 0.70 1.02E-05 0.96 0.4576 0.98 0.0865
Mucin 5AC, oligomeric
mucus/gel-forming (MUC5AC)
0.77 0.0561 0.61 0.0002 1.25 0.0464 0.56 0.0001 0.97 0.7651 1.04 0.0811
Mucin 7, secreted (MUC7) 0.86 0.3401 0.69 0.0217 0.94 0.6225 0.42 1.48E-06 0.63 0.0001 1.10 0.0012
NK CELL MARKERS
CD247 molecule (CD247) 1.12 0.0847 1.02 0.7505 1.00 0.9863 1.80 1.78E-15 1.06 0.2277 0.98 0.0376
Neural cell adhesion molecule 1
(NCAM1)
0.85 0.0590 0.76 0.0007 1.14 0.0524 1.79 3.62E-10 0.92 0.1385 1.00 0.9652
Natural cytotoxicity triggering
receptor 1 (NCR1)
1.11 0.1621 1.00 0.9473 1.13 0.0531 2.31 1.68E-22 1.07 0.2349 0.95 0.0002
PATTERN RECOGNITION RECEPTORS
Nucleotide-binding oligomerization
domain containing 2 (NOD2)
0.88 0.1748 1.21 0.0348 1.13 0.1221 1.08 0.4293 0.90 0.0932 0.99 0.4252
Toll-like receptor 2 (TLR2) 1.01 0.8677 1.01 0.9108 1.26 0.0013 0.84 0.0615 1.02 0.7880 0.98 0.1690
Toll-like receptor 4 (TLR4) 0.99 0.9140 1.20 0.0184 1.20 0.0039 1.02 0.8485 0.94 0.2395 0.97 0.0550
(Continued)
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TABLE 5 | Continued
Target TF TP TS Plasmid Sex (female)α Ageβ
FC p-value FC p-value FC p-value FC p-value FC p-value FC p-value
REGULATORS/SIGNALING PATHWAYS
CD274 molecule (CD274) 1.01 0.8828 1.44 0.0001 1.16 0.0507 2.47 1.18E-18 1.20 0.0046 0.95 0.0030
Chromodomain helicase DNA binding
protein 8 (CHD8)
0.93 0.0593 1.01 0.7501 1.04 0.2423 1.00 0.9029 0.98 0.4950 1.01 0.2923
COMM domain containing 6
(COMMD6)
0.99 0.9205 0.96 0.6492 1.00 0.9510 0.89 0.2836 0.99 0.8589 0.99 0.6788
Hematopoietically expressed
homeobox (HHEX )
1.34 8.54E-06 0.92 0.2204 1.07 0.1923 1.11 0.1411 1.04 0.3702 1.00 0.7584
IKAROS family zinc finger 1 (Ikaros)
(IKZF1)
1.11 0.0319 0.99 0.9105 1.04 0.3969 1.37 1.44E-08 1.00 0.9898 1.01 0.2868
Myeloid differentiation primary
response 88 (MYD88)
0.93 0.0303 1.05 0.1445 1.07 0.0151 1.00 0.9773 1.01 0.6856 1.00 0.6936
Marginal zone B and B1 cell-specific
protein (MZB1)
1.16 0.2162 1.24 0.0712 0.95 0.6338 2.07 8.27E-08 1.21 0.0279 0.98 0.3593
Nuclear factor of kappa light
polypeptide gene enhancer in B-cells
1 (NFKB1)
0.95 0.1251 1.06 0.1139 1.04 0.1457 1.13 0.0022 0.99 0.7545 1.00 0.5891
Phosphatidylinositol-3,4,5-
trisphosphate-dependent Rac
exchange factor 2 (PREX2v1)
1.06 0.5998 0.81 0.0744 0.90 0.2736 1.38 0.0115 0.95 0.5644 1.02 0.4858
Phosphatidylinositol-3,4,5-
trisphosphate-dependent Rac
exchange factor 2 (PREX2v2)
1.07 0.5708 1.08 0.5194 0.84 0.0985 1.05 0.6832 0.86 0.0769 1.03 0.1608
Ras homolog family member H
(RHOH)
1.20 0.0034 1.01 0.8137 1.03 0.6026 1.47 4.37E-08 1.11 0.0183 0.97 0.0227
SAM domain, SH3 domain and
nuclear localization signals 1
(SAMSN1)
1.03 0.6236 1.32 4.02E-05 1.04 0.5155 1.36 0.0001 1.05 0.2859 0.97 0.0229
Serpin peptidase inhibitor B3
(SERPINB3)
0.87 0.3173 1.90 6.73E-06 1.32 0.0175 2.65 8.33E-10 0.86 0.1311 0.94 0.0185
Serpin peptidase inhibitor clade B
member 4, (SERPINB4)
0.75 0.2648 2.85 0.0001 1.25 0.3075 4.38 1.95E-07 0.97 0.8763 1.02 0.7506
Suppressor of cytokine signaling 1
(SOCS1)
1.15 0.0606 1.10 0.2035 1.09 0.1646 2.06 1.08E-17 1.05 0.3178 0.94 6.95E-06
Suppressor of cytokine signaling 3
(SOCS3)
1.01 0.9205 1.50 4.53E-05 1.34 0.0004 1.21 0.0777 1.02 0.7518 0.93 0.0001
Serglycin (SRGN) 0.91 0.2568 1.28 0.0018 1.12 0.0767 0.97 0.7165 0.98 0.7288 0.99 0.6097
Signal transducer and activator of
transcription 1 (STAT1)
1.02 0.8024 1.12 0.0565 1.11 0.0391 1.97 1.34E-22 1.09 0.0392 0.95 9.97E-07
Signal transducer and activator of
transcription 3 (STAT3)
0.93 0.1345 1.06 0.1683 1.14 0.0007 1.00 0.9584 0.96 0.2153 0.98 0.0423
Signal transducer and activator of
transcription 4 (STAT4)
1.02 0.8085 1.00 0.9741 1.04 0.4556 1.85 5.37E-18 1.04 0.3692 0.98 0.0535
T-box 21 (TBX21) 1.21 0.0044 1.00 0.9917 1.07 0.2307 2.18 6.56E-25 1.11 0.0197 0.97 0.0060
Ubiquitin specific peptidase 6 (Tre-2
oncogene) (USP6)
0.70 0.1911 0.87 0.6216 0.72 0.1582 0.97 0.9124 0.65 0.0322 0.99 0.7936
αFC>1 indicates expression was greater in females than males.
βFC calculated with an age unit increase of 1 year.
FC = fold change. Using the Benjamini and Hochberg approach for adjusting for multiple comparisons, in order to control the false discovery rate <5% only tests with a p-value below
0.0142 (highlighted in bold) are considered statistically significant.
more susceptible to diseases resulting from immune-mediated
pathology (Klein and Flanagan, 2016).
Among infected individuals, the C. trachomatis plasmid:omcB
ratio (4.57:1) was very similar to the ratio reported from a range
of ocular and genital C. trachomatis isolates (mean 4.0:1) and
from a population-based trachoma study in Guinea Bissau (5.3:1)
(Pickett et al., 2005; Last et al., 2014). In common with the
study from Guinea Bissau, we did not find evidence of variation
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FIGURE 2 | Heatmap of the expression of each of the 83 retained genes in 458 individuals. Each row represents an individual, with individuals grouped as per their
disease and infection status and the relevant group indicated on the right: Group (A) Infected, Active Trachoma; (B) Infected, no Active Trachoma; (C) Uninfected,
Active Trachoma; (D) Uninfected, no Active Trachoma. 1CT values of genes are represented in the columns, with genes that tend to be expressed together located
next to one another. Red means that an individual has a higher expression of that gene, blue, a lower expression, relative to that individual’s expression of the
endogenous control gene HPRT1.
in the plasmid copy number with increasing disease severity
scores.
Host Gene Expression
IFNGwas strongly upregulated in association with C. trachomatis
infection, consistent with previous findings in trachoma endemic
populations (Burton et al., 2004; Holland et al., 2006; Natividad
et al., 2010). Several NK cell markers were also upregulated
in association with C. trachomatis infection: NCR1, CD56
(NCAM1), and CD247. IFNγ, NCAM1, and NCR1 were among
the genes most strongly associated with increased odds of
C. trachomatis infection, and Th1 and NK cell pathways were
enriched in this gene set (Table 6). A strong IFNG response
and transcriptional signatures associated with NK cell activation
and cytotoxicity were closely associated with C. trachomatis
infection and active trachoma in a West African population
(Natividad et al., 2010), and infiltrates suggestive of NK cells were
identified in scarred conjunctival biopsy tissue from individuals
with trachomatous trichiasis from Tanzania (Hu et al., 2016). In
peripheral blood from adults with trichiasis and controls that
were stimulated ex-vivo with C. trachomatis antigens, NK cells
and to a lesser extent CD8+ T cells were the major sources of
IFNγ with <50% of the IFNγ produced by CD4+ T cells (Gall
et al., 2011). In a non-human primate live-attenuated ocular
chlamydial vaccine study, depletion of CD8+ cells abrogated
protective immunity, however the contribution of CD4+ and
NK cells was not investigated (Olivares-Zavaleta et al., 2014).
IFNγ is a crucial component of the Th1 response to restrict
C. trachomatis survival via tryptophan depletion, macrophage
activation and promoting leukocyte adhesion, migration and
activation (Beatty et al., 1994; Mosser and Edwards, 2008;
Redgrove and McLaughlin, 2014). Interestingly, whilst IFNG
was strongly upregulated in individuals with C. trachomatis
infection, there was much less upregulation in individuals with
disease but not infection, suggesting that the IFNG response is
quickly down-regulated once C. trachomatis has been cleared.
Supporting this observation, cluster 3, which was enriched for
Th1, NK, IL-12, and IFNγ pathways, was strongly associated
with infection but not with TF or TP. Cluster 3 expression was
also marginally associated with female sex, and IFNG, IDO1,
IL12B, and IL19 were each upregulated in females relative to
males (Table 5). Both the number of activated CD4+ cells and
their relative expression of pro-inflammatory genes including
IFNG have previously been shown to be higher in females than
males (Hewagama et al., 2009; Sankaran-Walters et al., 2013).
Our data suggest that increased expression of IFNG and related
pathways in females may contribute to the observed differences
in tissue responsiveness (TP and TS) between the sexes in the
context of equal infection exposure. In support of this hypothesis,
a longitudinal study conducted in The Gambia that visited
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TABLE 6 | Lasso logistic regression of gene expression by infection, active
disease (in only uninfected individuals) and scarring status.
C. trachomatis
infection
Active trachoma
(uninfected only)
Scarring
IFNG HHEX IL33
IL17A CDH1v2 CXCL5
NCAM1 MMP9 IDO1
MZB1 MMP7 CCL2
CTGF IDO1 MUC5AC
NCR1 IL21 IL21
TYMS IFNG MMP9
SERPINB3 CXCL5 TLR2
IKZF1 RHOH PDGFB
MUC7 TNFRSF1B CD40
CD53 S100A4 CDH2
IL21 SPARCL1 IL10
IL12B VIM SERPINB3
SOCS1 MYD88 NCR1
TBX21 TNFRSF1A TTK
S100A7 NCAM1 BCL2
IL10 FOXP3 SOCS3
S100A4 FOXP3
MMP7 CCL18
CSF3 CTGF2
ALOX5 COMMD6
PDGFB SAMSN1
ACTA2 CD247
CDC25C
CDH2
FOXP3
STAT4
IL6
OVER-REPRESENTED PATHWAYS
IL-12 and STAT4
dependent signaling
pathway in Th1
development [15:3/3]*
Inflammatory Response
Pathway [32:3/4]
Immunoregulatory
interactions between a
Lymphoid and a
non-Lymphoid cell [211:3/4]
NO2-dependent IL-12
pathway in NK cells
[9:3/3]
Activation of Matrix
Metalloproteinases [31:2/2]
Signaling events mediated
by PTP1B [53:3/4]
Assembly of collagen fibrils
and other multimeric
structures [49:2/2]
Leukocyte transendothelial
migration [116:2/2]
Collagen formation [94:2/2]
TNFs bind their
physiological receptors
[30:2/2]
*[x:y/z] x = total number of genes in pathway, y = number of pathway genes present in
input list, z = number of pathway genes present in background.
For each outcome, the genes whose expression was most strongly associated are listed.
Biological pathways with members that are over-represented (P ≤ 0.05) in each gene list
relative to the background (all genes tested) are shown for each phenotype, in descending
order.
participants every 2 weeks found that the likelihood of developing
infection or active disease and the duration of infection were
independent of sex, however males had a reduced duration of
active disease relative to females (Grassly et al., 2008). Whilst
Th1 responses and IFNG are essential for controlling chlamydial
infection, excessive responses are thought to cause collateral
tissue damage and contribute to chlamydial pathology (Van
Voorhis et al., 1997; Rank et al., 2000). It is therefore possible that
a female predisposition to overproduce Th1 responses and IFNG
may tip the balance from protection toward pathological tissue
damage. However, further research is required to clarify this
hypothesis and a direct causal relationship cannot be determined
from this cross-sectional analysis.
The cytokine genes IL1β , IL6, IL17, IL21, IL22, IL23,
and TGFβ1 were strongly expressed in individuals with
C. trachomatis infection. Th17 cells are generated in the presence
of TGFβ1, IL-1β, IL-6, IL-21, and IL-23 and classically produce
IL-17, IL-22, and IL-21 (Manel et al., 2008; Zielinski et al., 2012).
IL21 expression was also upregulated in individuals with TF
and TS. Individuals with TP significantly upregulated IL17 and
IL23 expression and IL21 at marginal significance. The combined
expression of cluster 5, containing IL10, IL17A, IL21, CXCL13,
and MMP12, was significantly associated with C. trachomatis
infection, TF, TP, and TS. Th17 cells have important roles in
mucosal immunity against bacteria and fungi, however they
are also associated with the inflammatory pathology of diseases
such as Crohn’s disease, psoriasis and rheumatoid arthritis
(Tesmer et al., 2008). Epithelial cells stimulated by IL-17 and
IL-22 upregulate chemokines, cytokines, antimicrobial peptides
and growth factors such as IL-6, IL-8, S100A7, and GM-
CSF (CSF2) (Wolk et al., 2006; Eyerich et al., 2010); these
transcripts were upregulated in individuals with C. trachomatis
infection (S100A7 at marginal significance). IL8 and S100A7
were also upregulated in individuals with TP. IL-8 and S100A7,
amongst other factors induced by Th17 cells, are chemotactic for
neutrophils, an influx of which is associated with C. trachomatis
infection and contributes to pathology in animal models of
urogenital and ocular infection (Frazer et al., 2011; Lacy et al.,
2011). IL-22, which was highly upregulated with infection, is
also important in the maintenance of epithelial health and
barrier function (Radaeva et al., 2004; Rutz et al., 2013). The
relative contributions of IL-17 and associated responses to
protection from C. trachomatis infection and maintenance of
barrier function vs. pathological tissue damage remain unclear.
In murine models of genital C. trachomatis infection higher levels
of IL-17/Th17 cells have been associated with greater pathology
(Lu et al., 2012; Vicetti Miguel et al., 2016), whereas in IL-23
knock-out mice which had greatly reduced levels of IL-17 and
IL-22 there was no difference in infection burden or oviduct
pathology compared to wild type mice (Frazer et al., 2013).
Longitudinal investigation of these factors is expected to further
our understanding of the role of Th17 cell associated cytokines in
human chlamydial pathogenesis.
STAT1 and STAT4, which promote Th1 cell development
(Nishikomori et al., 2002; Mikhak et al., 2006; Zhu et al.,
2010), were upregulated in response to C. trachomatis infection.
STAT1 and STAT4 have previously been shown to be associated
with active trachoma and ocular C. trachomatis infection, and
STAT1 was upregulated in cervical epithelial cells infected with
C. trachomatis in vitro which was found to inhibit chlamydial
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growth (Lad et al., 2005; Natividad et al., 2010). STAT3, which
is required for Th17 development (Zhu et al., 2010; Yang
et al., 2011), was not differentially regulated, contrasting the
upregulation of Th17 cytokines. SOCS1, IL10, and FOXP3 were
upregulated in individuals with C. trachomatis infection and
SOCS3 and IL10 were upregulated in individuals with TS and
TP, indicative of inflammatory regulation. Upregulation of IL10
expression has previously been reported in individuals with
active trachoma and a genetic polymorphism in IL10 was
associated with trachomatous scarring (Mozzato-Chamay et al.,
2000; Burton et al., 2004; Natividad et al., 2005; Faal et al.,
2006; Skwor et al., 2008). However, the role of Tregs and IL-10
in trachoma remains unclear; dampening inflammation might
result in less tissue damage, but conversely it might also prolong
survival of C. trachomatis (Zhang et al., 2009).
MMP9, MMP12, TGFβ1, and PDGF were significantly
upregulated in individuals with C. trachomatis infection.MMP7,
MMP9, and MMP12 were upregulated in individuals with TP,
MMP9 was upregulated in TF and FGF2 and PDGF were
upregulated in individuals with TS. MMP7 was downregulated
in infected individuals. MMP7 has consistently been found to
be upregulated in scarring trachoma and trichiasis alongside
MMP9 and MMP12 but there is less evidence for a role of
MMP7 in active trachoma (Holland et al., 2010; Burton et al.,
2011b, 2015; Hu et al., 2012). Degradation of the extracellular
matrix and basement membrane by MMP9 and MMP12, in
part derived from macrophage and neutrophil degranulation
(Shapiro et al., 1993; Kjeldsen et al., 1994), facilitates connective
tissue remodeling and leukocyte migration into the epithelium
(Ozdemir et al., 1999; Zeng et al., 1999; Misko et al., 2002).
Whilst MMPs are an essential part of the wound healing process
(Nwomeh et al., 1998; Wolf et al., 2017), MMP9 overexpression
has been linked to aggressive contractile scarring in proliferative
vitroretinopathy and failure of rat corneal cells to re-epithelialize
following corneal injury (Fini et al., 1996; Kon et al., 1998).
SPARCL1 was down-regulated in individuals with
C. trachomatis infection, TF and TP, consistent with previous
studies (Hu et al., 2012; Burton et al., 2015). SPARCL1 codes for a
secreted glycoprotein which regulates extracellular matrix (ECM)
and cell-matrix adhesion (Girard and Springer, 1996) SPARCL1
inhibits cell proliferation and migration and reduced SPARCL1
expression has been linked to cancer metastases (Nelson et al.,
1998; Sullivan and Sage, 2004). In a murine corneal injury
model, knock-out of SPARCL1 led to excessive accumulation
of collagen type IV from myofibroblasts and irregular fibrotic
ECM formation (Chaurasia et al., 2013). Addition of exogenous
SPARCL1 rescued the wild type phenotype with a cessation
of collagen IV production, replacement with collagen I from
keratinocytes and restoration of normal ECM architecture.
Consistent with this, immunohistochemistry and histology
studies using tissue from individuals with scarring trachoma
have demonstrated a reduction in collagens I and III, an
increase in collagens IV and V and progressive disorganization
of collagen fibers in scarring trachoma relative to healthy
conjunctival tissue (Abu El-Asrar et al., 1998; Hu et al., 2013b;
Derrick et al., 2016b). Genes that were most strongly associated
with active trachoma in the absence of C. trachomatis infection
were enriched for pathways of leukocyte transendothelial
migration, TNF receptors, MMP activation, collagen formation
and assembly (Table 6). Active trachoma signs often persist after
the clearance of C. trachomatis infection (Grassly et al., 2008;
Burton et al., 2011a,c; Lee et al., 2014) and inflammation is linked
to progressive scarring (Ramadhani et al., 2016a). We found that
TP but not infection was associated with TS in the multivariable
model (Table 3). These results suggest that the inflammatory
phenotype following the clearance of C. trachomatis infection
is characterized by collagen formation and assembly, MMP-
mediated matrix remodeling and leukocyte influx, and that these
pathways might be causative factors in the scarring process.
We found significantly reduced expression of MUC1, MUC4,
MUC5AC, and MUC7 in individuals with C. trachomatis
infection, and MUC5AC expression was reduced in those with
TP. MUC1 and MUC4 are primarily expressed by apical cells
of the stratified epithelia, MUC7 by lacrimal gland epithelia
and MUC5AC by goblet cells (Gipson and Argueso, 2003).
MUC7 expression was also significantly reduced in females
relative to males. MUC5AC and MUC7 down-regulation has
previously been reported in individuals with trachomatous
trichiasis, however expression ofMUC1 andMUC4was increased
in this later stage of disease (Burton et al., 2011b). IL-22
stimulates the upregulation of MUC4 and MUC1, therefore, one
might expect a corresponding increase in mucin expression in
infected individuals (Turner et al., 2013). This inconsistency
and the broad reduction in mucin expression during infection
may reflect a loss of epithelial homeostasis and a potential
reduction in barrier function. This in turn could result in
increased access of bacteria to the epithelial cell surface,
promoting inflammation. In patients with ulcerative colitis,
reduction of goblet cells, mucin production and microbial
diversity were identified as causative factors in disease etiology
(Alipour et al., 2016). Microbial dysbiosis can itself be caused by
inflammation, creating a positive feedback loop (Winter et al.,
2013). Decreased diversity has previously been found in the
conjunctival microbiome of individuals with scarring trachoma
relative to healthy controls (Zhou et al., 2014). Furthermore,
penetration of the mucin barrier and contact between epithelial
cells and bacteria was demonstrated in ulcerative colitis patients
with acute inflammation, whereas the mucin barrier of healthy
controls was impenetrable (Johansson et al., 2014). It is tempting
to speculate that reduced barrier function resulting from
inflammation and loss of mucins causes microbial dysbiosis
and contact between bacteria and epithelial cells, leading to
persistent conjunctival inflammation, which in turn contributes
to trachomatous scarring.
Consistent with our previous studies in various clinical stages
of trachoma (Burton et al., 2011b,c, 2012, 2015; Hu et al., 2012),
the antimicrobial peptide S100A7 was upregulated in individuals
with TP and was marginally associated with C. trachomatis
infection. S100A7 is secreted by epithelial cells in response to
microbial challenge and expression can also be stimulated by
IL-22 (Wolk et al., 2006). It is chemotactic for neutrophils and
interferes with pathogen membrane permeability and enzyme
function (Ganz, 2003; Guilhelmelli et al., 2013). The upregulation
of S100A7 in various clinical stages of trachoma could support the
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loss of epithelial barrier function hypothesis described above and
could contribute to chronic inflammation.
There was differential expression of several cell cycle genes
(CD53, CDK13, CDC25C, PHYH, TYMS, TTK, TP53) in
individuals with C. trachomatis infection and/or TP (Table 5).
These expression changes could reflect regulation of the cell
cycle in response to infection or inflammation, such as the
proliferation or contraction of infiltrating inflammatory cells
and cells effecting the wound healing response. Studies have
reported that progression of the cell cycle is slow in cells infected
with C. trachomatis (Kun et al., 2013; Elwell et al., 2016) and
C. trachomatis is known to interfere with host cell apoptosis as
a survival mechanism (Fischer et al., 2004; Ying et al., 2007;
Siegl et al., 2014). Cluster 1 was enriched for genes in apoptosis
pathways, however the combined expression of this cluster was
not associated with clinical phenotypes or infection.
CONCLUSIONS
Our results, illustrated in a graphical summary (Figure 3),
suggest that IFNG and IL22 were acutely upregulated in
response to C. trachomatis infection and expression appeared
to be reduced following the clearance of infection, despite the
persistence of inflammation. This might suggest that the sources
of these cytokines are important in the clearance of infection
and that the inflammatory phenotype differs once infection has
been cleared, shifting away from a Th1/NK cell dominated
response. The upregulation of Th17 cell-associated cytokines
in infection and TP phenotypes implies the involvement of
Th17 cells, although it remains unclear whether they contribute
more to protection or pathology. Epithelial cells appear to
be highly active, with possible loss of epithelial homeostasis
and barrier function resulting in loss of mucins and a pro-
inflammatory anti-microbial phenotype, perhaps exacerbating
inflammation. The upregulation of growth factors and MMPs,
derived in part from infiltrating macrophages and neutrophils,
and the down-regulation of SPARCL1 are likely to contribute
to matrix remodeling, collagen deposition and conjunctival
scarring in the post-infection inflammatory phase. Females were
more susceptible to TP and TS and although this was not
associated with a significant difference in infection prevalence,
there was some evidence of increased IFNG related pathway
activity in females. A caveat of this study is that gene expression
may not correlate directly to protein expression and this
will require further work. Despite this, we anticipate that
FIGURE 3 | Graphical summary illustrating the host immune pathways hypothesized to be associated with different trachoma phenotypes. Genes most strongly
associated with each phenotype are shown in italics with the direction and strength of expression illustrated by arrows. Pathways that were most enriched for each
phenotype are shown. Ct EBs, C. trachomatis elementary bodies; N, epithelial cell nucleus; NK, Natural killer cells; Th1, Th1 T cells; Th17, Th17 T cells; PMN,
neutrophil; Mφ, macrophage; red cross-hatching, fibrosis. The mucus layer is shown in green, the epithelial cell layer in blue, and the stroma in beige.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 15 September 2017 | Volume 7 | Article 406
Ramadhani et al. Conjunctival Gene Expression and Trachoma
longitudinal investigation of these transcriptional signatures and
relation to infection and ongoing clinical signs will enhance our
understanding of their relative contributions to protection and
pathology.
AUTHOR CONTRIBUTIONS
Substantial contributions to the conception: MB, MH, DCM,
and RB. Design of the work: MB, AR, MH, PM, TM and
CR. Analysis: AR, MB, DM, MH, TD, and DJ. Interpretation
of data for the work: AR, MB, MH, and TD. Drafting
the work: AR and MB. Revising it critically for important
intellectual content: AR, MB, MH, TD, DCM, RB, DM, CR,
PM, TM, and DJ. Final approval of the version to be published:
AR, MB, MH, TD, DCM, RB, DM, CR, PM, TM, and DJ.
Agreement to be accountable for all aspects of the work in
ensuring that questions related to the accuracy or integrity
of any part of the work are appropriately investigated and
resolved: AR, MB, MH, TD, DCM, RB, DM, CR, PM, TM,
and DJ.
FUNDING
This work is supported by the Wellcome Trust grant number
098481/Z/12/Z.
ACKNOWLEDGMENTS
We express our gratitude to the field team and to the study
participants.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fcimb.
2017.00406/full#supplementary-material
REFERENCES
Abu El-Asrar, A. M., Geboes, K., Al-Kharashi, S. A., Al-Mosallam, A. A., Tabbara,
K. F., Al-Rajhi, A. A., et al. (1998). An immunohistochemical study of
collagens in trachoma and vernal keratoconjunctivitis. Eye 12(Pt 6), 1001–1006.
doi: 10.1038/eye.1998.257
Alipour, M., Zaidi, D., Valcheva, R., Jovel, J., Martinez, I., Sergi, C., et al.
(2016). Mucosal barrier depletion and loss of bacterial diversity are primary
abnormalities in paediatric ulcerative colitis. J. Crohns. Colitis 10, 462–471.
doi: 10.1093/ecco-jcc/jjv223
Beatty, W. L., Belanger, T. A., Desai, A. A., Morrison, R. P., and Byrne, G. I.
(1994). Tryptophan depletion as a mechanism of gamma interferon-mediated
chlamydial persistence. Infect. Immun. 62, 3705–3711.
Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate:a
practical and powerful approach to multiple testing. J. R. Statist. Soc. 57,
289–300.
Bobo, L., Novak, N., Mkocha, H., Vitale, S., West, S., and Quinn, T. C. (1996).
Evidence for a predominant proinflammatory conjunctival cytokine response
in individuals with trachoma. Infect. Immun. 64, 3273–3279.
Bourne, R. R., Stevens, G. A., White, R. A., Smith, J. L., Flaxman, S. R., Price,
H., et al. (2013). Causes of vision loss worldwide, 1990-2010: a systematic
analysis. Lancet Glob. Health 1, E339–E349. doi: 10.1016/S2214-109X(13)
70113-X
Burton, M. J., Bailey, R. L., Jeffries, D., Mabey, D. C., and Holland, M. J.
(2004). Cytokine and fibrogenic gene expression in the conjunctivas of subjects
from a gambian community where trachoma is endemic. Infect. Immun. 72,
7352–7356. doi: 10.1128/IAI.72.12.7352-7356.2004
Burton, M. J., Holland, M. J., Faal, N., Aryee, E. A., Alexander, N. D., Bah, M., et al.
(2003). Which members of a community need antibiotics to control trachoma?
conjunctival Chlamydia trachomatis infection load in gambian villages. Invest.
Ophthalmol. Vis. Sci. 44, 4215–4222. doi: 10.1167/iovs.03-0107
Burton, M. J., Hu, V. H., Massae, P., Burr, S. E., Chevallier, C., Afwamba, I. A.,
et al. (2011a). What is causing active trachoma? the role of non-chlamydial
bacterial pathogens in a low prevalence setting. Invest. Ophthalmol. Vis. Sci. 52,
6012–6017. doi: 10.1167/iovs.11-7326
Burton, M. J., Rajak, S. N., Bauer, J., Weiss, H. A., Tolbert, S. B., Shoo, A., et al.
(2011b). Conjunctival transcriptome in scarring trachoma. Infect. Immun. 79,
499–511. doi: 10.1128/IAI.00888-10
Burton,M. J., Rajak, S. N., Hu, V. H., Ramadhani, A., Habtamu, E., Massae, P., et al.
(2015). Pathogenesis of progressive scarring trachoma in ethiopia and tanzania
and its implications for disease control: two cohort studies. PLoS Negl. Trop.
Dis. 9:E0003763. doi: 10.1371/journal.pntd.0003763
Burton, M. J., Rajak, S. N., Ramadhani, A., Weiss, H. A., Habtamu, E., Abera, B.,
et al. (2012). Post-operative recurrent trachomatous trichiasis is associated with
increased conjunctival expression of S100a7 (Psoriasin). PLoS Negl. Trop. Dis.
6:E1985. doi: 10.1371/journal.pntd.0001985
Burton, M. J., Ramadhani, A., Weiss, H. A., Hu, V., Massae, P., Burr, S. E.,
et al. (2011c). Active trachoma is associated with increased conjunctival
expression of Il17a and profibrotic cytokines. Infect. Immun. 79, 4977–4983.
doi: 10.1128/IAI.05718-11
Chaurasia, S. S., Perera, P. R., Poh, R., Lim, R. R., Wong, T. T., and Mehta, J.
S. (2013). Hevin plays a pivotal role in corneal wound healing. PLoS ONE
8:E81544. doi: 10.1371/journal.pone.0081544
Dawson, C. R., Jones, B. R., and Tarizzo, M. L. (1981). Guide to Trachoma Control.
Geneva: World Health Organization.
Dawson, C. R., Marx, R., Daghfous, T., Juster, R., and Schachter, J. (1990).
What clinical signs are critical in evaluating the intervention in trachoma?
in Chlamydial Infections, ed W. R. Bowie (Cambridge: Cambridge University
Press), 271–278.
Derrick, T., Last, A. R., Burr, S. E., Roberts, C. H., Nabicassa, M., Cassama, E., et al.
(2016a). Inverse relationship between microrna-155 And -184 expression with
increasing conjunctival inflammation during ocular Chlamydia trachomatis
infection. BMC Infect. Dis. 16, 60. doi: 10.1186/s12879-016-1367-8
Derrick, T., Luthert, P. J., Jama, H., Hu, V. H., Massae, P., Essex, D., et al.
(2016b). Increased epithelial expression of ctgf and S100a7 with elevated
subepithelial expressionOf Il-1beta in trachomatous trichiasis. PLoSNegl. Trop.
Dis. 10:E0004752. doi: 10.1371/journal.pntd.0004752
Derrick, T., Roberts, C., Rajasekhar, M., Burr, S. E., Joof, H., Makalo, P.,
et al. (2013). Conjunctival microrna expression in inflammatory trachomatous
scarring. PLoS Negl. Trop. Dis. 7:E2117. doi: 10.1371/journal.pntd.0002117
Elwell, C., Mirrashidi, K., and Engel, J. (2016). Chlamydia cell biology and
pathogenesis. Nat. Rev. Microbiol. 14, 385–400. doi: 10.1038/nrmicro.2016.30
Eyerich, S., Eyerich, K., Cavani, A., and Schmidt-Weber, C. (2010). Il-17 and Il-22:
siblings, not twins. Trends Immunol. 31, 354–361. doi: 10.1016/j.it.2010.06.004
Faal, N., Bailey, R. L., Jeffries, D., Joof, H., Sarr, I., Laye, M., et al. (2006).
Conjunctival Foxp3 expression in trachoma: do regulatory t cells have a
role in human ocular Chlamydia trachomatis infection? PLoS Med. 3:E266.
doi: 10.1371/journal.pmed.0030266
Fini, M. E., Parks, W. C., Rinehart, W. B., Girard, M. T., Matsubara, M., Cook, J.
R., et al. (1996). Role of matrix metalloproteinases in failure to re-epithelialize
after corneal injury. Am. J. Pathol. 149, 1287–1302.
Fischer, S. F., Vier, J., Kirschnek, S., Klos, A., Hess, S., Ying, S., et al. (2004).
Chlamydia inhibit host cell apoptosis by degradation of proapoptotic Bh3-only
proteins. J. Exp. Med. 200, 905–916. doi: 10.1084/jem.20040402
Frazer, L. C., O’connell, C. M., Andrews, C. W. Jr., Zurenski, M. A., and Darville,
T. (2011). Enhanced neutrophil longevity and recruitment contribute to the
severity of oviduct pathology during Chlamydia muridarum infection. Infect.
Immun. 79, 4029–4041. doi: 10.1128/IAI.05535-11
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 16 September 2017 | Volume 7 | Article 406
Ramadhani et al. Conjunctival Gene Expression and Trachoma
Frazer, L. C., Scurlock, A. M., Zurenski, M. A., Riley, M. M., Mintus, M., Pociask,
D. A., et al. (2013). Il-23 Induces Il-22 and Il-17 production in response
to Chlamydia muridarum genital tract infection, but the absence of these
cytokines does not influence disease pathogenesis. Am. J. Reprod. Immunol. 70,
472–484. doi: 10.1111/aji.12171
Gall, A., Horowitz, A., Joof, H., Natividad, A., Tetteh, K., Riley, E., et al. (2011).
Systemic effector and regulatory immune responses to chlamydial antigens in
trachomatous trichiasis. Front. Microbiol. 2:10. doi: 10.3389/fmicb.2011.00010
Ganz, T. (2003). The role of antimicrobial peptides in innate immunity. Integr.
Comp. Biol. 43, 300–304. doi: 10.1093/icb/43.2.300
Gipson, I. K., and Argueso, P. (2003). Role of mucins in the function
of the corneal and conjunctival epithelia. Int. Rev. Cytol. 231, 1–49.
doi: 10.1016/S0074-7696(03)31001-0
Girard, J. P., and Springer, T. A. (1996). Modulation of endothelial cell adhesion by
hevin, an acidic protein associated with high endothelial venules. J. Biol. Chem.
271, 4511–4517. doi: 10.1074/jbc.271.8.4511
Grassly, N. C., Ward, M. E., Ferris, S., Mabey, D. C., and Bailey, R.
L. (2008). The natural history of trachoma infection and disease in a
gambian cohort with frequent follow-up. PLoS Negl. Trop. Dis. 2:E341.
doi: 10.1371/journal.pntd.0000341
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski Lda, S., Silva-Pereira,
I., and Kyaw, C. M. (2013). Antibiotic development challenges: the various
mechanisms of action of antimicrobial peptides and of bacterial resistance.
Front. Microbiol. 4:353. doi: 10.3389/fmicb.2013.00353
Hewagama, A., Patel, D., Yarlagadda, S., Strickland, F. M., and Richardson, B. C.
(2009). Stronger inflammatory/cytotoxic t-cell response in women identified
by microarray analysis. Genes Immun. 10, 509–516. doi: 10.1038/gene.2009.12
Holland, M. J., Faal, N., Sarr, I., Joof, H., Laye, M., Cameron, E., et al. (2006).
The Frequency Of Chlamydia trachomatis major outer membrane protein-
specific Cd8+ T lymphocytes in active trachoma is associated with current
ocular infection. Infect. Immun. 74, 1565–1572. doi: 10.1128/IAI.74.3.1565-
1572.2006
Holland, M. J., Jeffries, D., Pattison, M., Korr, G., Gall, A., Joof, H., et al.
(2010). Pathway-focused arrays reveal increased matrix metalloproteinase-7
(matrilysin) transcription in trachomatous trichiasis. Invest. Ophthalmol. Vis.
Sci. 51, 3893–3902. doi: 10.1167/iovs.09-5054
Hu, V. H., Holland, M. J., and Burton, M. J. (2013a). Trachoma: protective and
pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl.
Trop. Dis. 7:E2020. doi: 10.1371/journal.pntd.0002020
Hu, V. H., Holland, M. J., Cree, I. A., Pullin, J., Weiss, H. A., Massae, P., et al.
(2013b). In vivo confocal microscopy and histopathology of the conjunctiva
in trachomatous scarring and normal tissue: a systematic comparison. Br. J.
Ophthalmol. 97, 1333–1337. doi: 10.1136/bjophthalmol-2013-303126
Hu, V. H., Luthert, P. J., Derrick, T., Pullin, J., Weiss, H. A., Massae, P.,
et al. (2016). Immunohistochemical analysis of scarring trachoma indicates
infiltration by natural killer and undefined Cd45 negative cells. PLoS Negl. Trop.
Dis. 10:E0004734. doi: 10.1371/journal.pntd.0004734
Hu, V. H., Massae, P., Weiss, H. A., Chevallier, C., Onyango, J. J., Afwamba, I. A.,
et al. (2011). Bacterial infection in scarring trachoma. Invest. Ophthalmol. Vis.
Sci. 52, 2181–2186. doi: 10.1167/iovs.10-5829
Hu, V. H., Weiss, H. A., Ramadhani, A. M., Tolbert, S. B., Massae, P., Mabey,
D. C., et al. (2012). Innate immune responses and modified extracellular
matrix regulation characterize bacterial infection and cellular/connective
tissue changes in scarring trachoma. Infect. Immun. 80, 121–130.
doi: 10.1128/IAI.05965-11
Johansson, M. E., Gustafsson, J. K., Holmen-Larsson, J., Jabbar, K. S., Xia,
L., Xu, H., et al. (2014). Bacteria penetrate the normally impenetrable
inner colon mucus layer in both murine colitis models and patients
with ulcerative colitis. Gut 63, 281–291. doi: 10.1136/gutjnl-2012-
303207
Kechagia, J. Z., Ezra, D. G., Burton, M. J., and Bailly, M. (2016). Fibroblasts
profiling in scarring trachoma identifies Il-6 as a functional component of a
fibroblast-macrophage pro-fibrotic and pro-inflammatory feedback loop. Sci.
Rep. 6:28261. doi: 10.1038/srep28261
Kjeldsen, L., Sengelov, H., Lollike, K., Nielsen, M. H., and Borregaard, N. (1994).
Isolation and characterization of gelatinase granules from human neutrophils.
Blood 83, 1640–1649.
Klein, S. L., and Flanagan, K. L. (2016). Sex differences in immune responses. Nat.
Rev. Immunol. 16, 626–638. doi: 10.1038/nri.2016.90
Kon, C. H., Occleston, N. L., Charteris, D., Daniels, J., Aylward, G. W., and Khaw,
P. T. (1998). A prospective study of matrix metalloproteinases in proliferative
vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 39, 1524–1529.
Kun, D., Xiang-Lin, C., Ming, Z., and Qi, L. (2013). Chlamydia inhibit host cell
apoptosis by inducing Bag-1 via the mapk/erk survival pathway. Apoptosis 18,
1083–1092. doi: 10.1007/s10495-013-0865-z
Lacy, H. M., Bowlin, A. K., Hennings, L., Scurlock, A. M., Nagarajan, U. M., and
Rank, R. G. (2011). Essential role for neutrophils in pathogenesis and adaptive
immunity inChlamydia caviae ocular infections. Infect. Immun. 79, 1889–1897.
doi: 10.1128/IAI.01257-10
Lad, S. P., Fukuda, E. Y., Li, J., De La Maza, L. M., and Li, E. (2005). Up-regulation
of the jak/stat1 signal pathway during Chlamydia trachomatis infection. J.
Immunol. 174, 7186–7193. doi: 10.4049/jimmunol.174.11.7186
Last, A. R., Roberts, C., Cassama, E., Nabicassa, M., Molina-Gonzalez, S., Burr,
S. E., et al. (2014). Plasmid copy number and disease severity in naturally
occurring ocular Chlamydia trachomatis infection. J. Clin. Microbiol. 52,
324–327. doi: 10.1128/JCM.02618-13
Lee, J. S., Munoz, B. E., Mkocha, H., Gaydos, C. A., Quinn, T. C., and West,
S. K. (2014). The effect of multiple rounds of mass drug administration
on the association between ocular Chlamydia trachomatis infection and
follicular trachoma in preschool-aged children. PLoS Negl. Trop. Dis. 8:E2761.
doi: 10.1371/journal.pntd.0002761
Lu, C., Zeng, H., Li, Z., Lei, L., Yeh, I. T., Wu, Y., et al. (2012). Protective immunity
against mouse upper genital tract pathology correlates with high ifngamma
but low Il-17 T cell and anti-secretion protein antibody responses induced
by replicating chlamydial organisms in the airway. Vaccine 30, 475–485.
doi: 10.1016/j.vaccine.2011.10.059
Manel, N., Unutmaz, D., and Littman, D. R. (2008). The differentiation of human
TH-17 cells requires transforming growth factor-beta and induction of the
nuclear receptor rorgammat. Nat. Immunol. 9, 641–649. doi: 10.1038/ni.1610
Michel, C. E., Roper, K. G., Divena, M. A., Lee, H. H., and Taylor, H. R. (2011).
Correlation of clinical trachoma and infection in aboriginal communities. PLoS
Negl. Trop. Dis. 5:E986. doi: 10.1371/journal.pntd.0000986
Mikhak, Z., Fleming, C. M., Medoff, B. D., Thomas, S. Y., Tager, A. M.,
Campanella, G. S., et al. (2006). Stat1 in peripheral tissue differentially regulates
homing of antigen-specific Th1 and Th2 cells. J. Immunol. 176, 4959–4967.
doi: 10.4049/jimmunol.176.8.4959
Misko, A., Ferguson, T., and Notterpek, L. (2002). Matrix Metalloproteinase
mediated degradation of basement membrane proteins in trembler J
neuropathy nerves. J. Neurochem. 83, 885–894. doi: 10.1046/j.1471-4159.
2002.01200.x
Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of
macrophage activation. Nat. Rev. Immunol. 8, 958–969. doi: 10.1038/nri2448
Mozzato-Chamay, N., Mahdi, O. S., Jallow, O., Mabey, D. C., Bailey, R. L., and
Conway, D. J. (2000). Polymorphisms in candidate genes and risk of scarring
trachoma in a Chlamydia trachomatis–endemic population. J. Infect. Dis. 182,
1545–1548. doi: 10.1086/315891
Natividad, A., Freeman, T. C., Jeffries, D., Burton, M. J., Mabey, D. C., Bailey,
R. L., et al. (2010). Human conjunctival transcriptome analysis reveals the
prominence of innate defense in Chlamydia trachomatis infection. Infect.
Immun. 78, 4895–4911. doi: 10.1128/IAI.00844-10
Natividad, A., Wilson, J., Koch, O., Holland, M. J., Rockett, K., Faal, N., et al.
(2005). Risk of trachomatous scarring and trichiasis in gambians varies with
snp haplotypes at the interferon-gamma and interleukin-10 loci.Genes Immun.
6, 332–340. doi: 10.1038/sj.gene.6364182
Nelson, P. S., Plymate, S. R., Wang, K., True, L. D., Ware, J. L., Gan, L., et al.
(1998). Hevin, an antiadhesive extracellular matrix protein, is down-regulated
in metastatic prostate adenocarcinoma. Cancer Res. 58, 232–236.
Nishikomori, R., Usui, T., Wu, C. Y., Morinobu, A., O’shea, J. J., and Strober,
W. (2002). Activated Stat4 has an essential role in Th1 differentiation
and proliferation that is independent of its role in the maintenance of
Il-12r beta 2 chain expression and signaling. J. Immunol. 169, 4388–4398.
doi: 10.4049/jimmunol.169.8.4388
Nwomeh, B. C., Liang, H. X., Diegelmann, R. F., Cohen, I. K., and Yager, D.
R. (1998). Dynamics of the matrix metalloproteinases mmp-1 and Mmp-
8 in acute open human dermal wounds. Wound Repair Regen. 6, 127–134.
doi: 10.1046/j.1524-475X.1998.60206.x
Olivares-Zavaleta, N., Whitmire, W. M., Kari, L., Sturdevant, G. L., and Caldwell,
H. D. (2014). Cd8+ T cells define an unexpected role in live-attenuated vaccine
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 17 September 2017 | Volume 7 | Article 406
Ramadhani et al. Conjunctival Gene Expression and Trachoma
protective immunity against Chlamydia trachomatis infection in macaques.
J. Immunol. 192, 4648–4654. doi: 10.4049/jimmunol.1400120
Ozdemir, E., Kakehi, Y., Okuno, H., and Yoshida, O. (1999). Role of
matrix metalloproteinase-9 in the basement membrane destruction
of superficial urothelial carcinomas. J. Urol. 161, 1359–1363.
doi: 10.1016/S0022-5347(01)61684-7
Pickett, M. A., Everson, J. S., Pead, P. J., and Clarke, I. N. (2005). The plasmids
of Chlamydia trachomatis and chlamydophila pneumoniae (N16): accurate
determination of copy number and the paradoxical effect of plasmid-curing
agents.Microbiology 151, 893–903. doi: 10.1099/mic.0.27625-0
Radaeva, S., Sun, R., Pan, H. N., Hong, F., and Gao, B. (2004). Interleukin 22
(Il-22) plays a protective role in T cell-mediated murine hepatitis: Il-22 is a
survival factor for hepatocytes via stat3 activation. Hepatology 39, 1332–1342.
doi: 10.1002/hep.20184
Ramadhani, A. M., Derrick, T., Holland, M. J., and Burton, M. J. (2016a). Blinding
trachoma: systematic review of rates and risk factors for progressive disease.
PLoS Negl. Trop. Dis. 10:E0004859. doi: 10.1371/journal.pntd.0004859
Ramadhani, A. M., Derrick, T., Macleod, D., Holland, M. J., and Burton, M.
J. (2016b). The relationship between active trachoma and ocular Chlamydia
trachomatis infection before and after mass antibiotic treatment. PLoS Negl.
Trop. Dis. 10:E0005080. doi: 10.1371/journal.pntd.0005080
Rank, R. G., Bowlin, A. K., and Kelly, K. A. (2000). Characterization of
lymphocyte response in the female genital tract during ascending chlamydial
genital infection in the guinea pig model. Infect. Immun. 68, 5293–5298.
doi: 10.1128/IAI.68.9.5293-5298.2000
Redgrove, K. A., and McLaughlin, E. A. (2014). The role of the immune response
in Chlamydia trachomatis infection of the male genital tract: a double-edged
sword. Front. Immunol. 5:534. doi: 10.3389/fimmu.2014.00534
Roberts, C. H., Franklin, C. S., Makalo, P., Joof, H., Sarr, I., Mahdi, O. S., et al.
(2015). Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis
intracellular infection: a genome wide association study. Sci. Rep. 5:17447.
doi: 10.1038/srep17447
Roberts, C. H., Last, A., Molina-Gonzalez, S., Cassama, E., Butcher, R., Nabicassa,
M., et al. (2013). Development and evaluation of a next-generation digital pcr
diagnostic assay for ocular Chlamydia trachomatis infections. J. Clin. Microbiol.
51, 2195–2203. doi: 10.1128/JCM.00622-13
Rutz, S., Eidenschenk, C., and Ouyang, W. (2013). Il-22, not simply a Th17
cytokine. Immunol. Rev. 252, 116–132. doi: 10.1111/imr.12027
Sankaran-Walters, S., Macal, M., Grishina, I., Nagy, L., Goulart, L., Coolidge, K.,
et al. (2013). Sex differences matter in the gut: effect on mucosal immune
activation and inflammation. Biol. Sex Differ. 4:10. doi: 10.1186/2042-6410-4-10
Shapiro, S. D., Kobayashi, D. K., and Ley, T. J. (1993). Cloning and characterization
of a unique elastolytic metalloproteinase produced by human alveolar
macrophages. J. Biol. Chem. 268, 23824–23829.
Siegl, C., Prusty, B. K., Karunakaran, K., Wischhusen, J., and Rudel, T. (2014).
Tumor Suppressor P53 alters host cell metabolism to limit Chlamydia
trachomatis infection. Cell Rep. 9, 918–929. doi: 10.1016/j.celrep.2014.10.004
Skwor, T. A., Atik, B., Kandel, R. P., Adhikari, H. K., Sharma, B., and Dean, D.
(2008). Role of secreted conjunctival mucosal cytokine and chemokine proteins
in different stages of trachomatous disease. PLoS Negl. Trop. Dis. 2:E264.
doi: 10.1371/journal.pntd.0000264
Solomon, A. W., Holland, M. J., Burton, M. J., West, S. K., Alexander,
N. D., Aguirre, A., et al. (2003). Strategies for control of trachoma:
observational study with quantitative Pcr. Lancet 362, 198–204.
doi: 10.1016/S0140-6736(03)13909-8
Sullivan, M. M., and Sage, E. H. (2004). Hevin/Sc1, A matricellular glycoprotein
and potential tumor-suppressor of the Sparc/Bm-40/osteonectin family. Int. J.
Biochem. Cell Biol. 36, 991–996. doi: 10.1016/j.biocel.2004.01.017
Taylor, H. R., Burton, M. J., Haddad, D., West, S., and Wright, H. (2014).
Trachoma. Lancet 384, 2142–2152. doi: 10.1016/S0140-6736(13)62182-0
Tesmer, L. A., Lundy, S. K., Sarkar, S., and Fox, D. A. (2008). Th17 cells in human
disease. Immunol. Rev. 223, 87–113. doi: 10.1111/j.1600-065X.2008.00628.x
Thylefors, B., Dawson, C. R., Jones, B. R., West, S. K., and Taylor, H. R. (1987).
A simple system for the assessment of trachoma and its complications. Bull.
World Health Organ. 65, 477–483.
Tibshirani, R. (1997). The lasso method for variable selection in
the cox model. Stat. Med. 16, 385–395. doi: 10.1002/(SICI)1097-
0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
Turner, J. E., Stockinger, B., and Helmby, H. (2013). Il-22 Mediates Goblet cell
hyperplasia and worm expulsion in intestinal helminth infection. PLoS Pathog.
9:E1003698. doi: 10.1371/journal.ppat.1003698
Van Voorhis, W. C., Barrett, L. K., Sweeney, Y. T., Kuo, C. C., and Patton, D.
L. (1997). Repeated Chlamydia trachomatis infection of Macaca nemestrina
fallopian tubes produces a Th1-like cytokine response associated with fibrosis
and scarring. Infect. Immun. 65, 2175–2182.
Vicetti Miguel, R. D., Quispe Calla, N. E., Pavelko, S. D., and Cherpes, T. L.
(2016). Intravaginal Chlamydia trachomatis challenge infection elicits Th1
and Th17 immune responses in mice that promote pathogen clearance and
genital tract damage. PLoS ONE 11:E0162445. doi: 10.1371/journal.pone.01
62445
West, S. K., Munoz, B., Mkocha, H., Hsieh, Y. H., and Lynch, M. C. (2001).
Progression of active trachoma to scarring in a cohort of tanzanian children.
Ophthalmic Epidemiol. 8, 137–144. doi: 10.1076/opep.8.2.137.4158
Winter, S. E., Lopez, C. A., and Baumler, A. J. (2013). The dynamics of
gut-associated microbial communities during inflammation. EMBO Rep. 14,
319–327. doi: 10.1038/embor.2013.27
Wolf, M., Maltseva, I., Clay, S. M., Pan, P., Gajjala, A., and Chan, M. F. (2017).
Effects of Mmp12 on cell motility and inflammation during corneal epithelial
repair. Exp. Eye Res. 160, 11–20. doi: 10.1016/j.exer.2017.04.007
Wolk, K., Witte, E., Wallace, E., Docke, W. D., Kunz, S., Asadullah, K., et al.
(2006). Il-22 regulates the expression of genes responsible for antimicrobial
defense, cellular differentiation, and mobility in keratinocytes: a potential role
in psoriasis. Eur. J. Immunol. 36, 1309–1323. doi: 10.1002/eji.200535503
Wolle, M. A., Munoz, B. E., Mkocha, H., and West, S. K. (2009b). Constant ocular
infection with Chlamydia trachomatis predicts risk of scarring in children in
tanzania. Ophthalmology 116, 243–247. doi: 10.1016/j.ophtha.2008.09.011
Wolle, M. A., Munoz, B., Mkocha, H., andWest, S. K. (2009a). Age, sex, and cohort
effects in a longitudinal study of trachomatous scarring. Invest. Ophthalmol. Vis.
Sci. 50, 592–596. doi: 10.1167/iovs.08-2414
World Health Organization (2016). Eliminating Trachoma: Accelerating Towards
2020. London, UK.
Yang, X. P., Ghoreschi, K., Steward-Tharp, S. M., Rodriguez-Canales, J., Zhu, J.,
Grainger, J. R., et al. (2011). Opposing regulation of the locus encoding Il-17
through direct, reciprocal actions of stat3 and stat5.Nat. Immunol. 12, 247–254.
doi: 10.1038/ni.1995
Ying, S., Pettengill, M., Ojcius, D. M., and Hacker, G. (2007). Host-cell survival
and death during chlamydia infection. Curr. Immunol. Rev. 3, 31–40.
doi: 10.2174/157339507779802179
Zeng, Z. S., Cohen, A. M., and Guillem, J. G. (1999). Loss of basement membrane
type iv collagen is associated with increased expression of metalloproteinases
2 and 9 (Mmp-2 and Mmp-9) during human colorectal tumorigenesis.
Carcinogenesis 20, 749–755. doi: 10.1093/carcin/20.5.749
Zhang, H., Liu, D., Sun, S., Liu, J., Wu, S., Mao, Y., et al. (2009). Selective expression
of calcium-binding protein S100a7 in lung cancer. Zhongguo. Fei. Ai. Za. Zhi.
12, 54–58. doi: 10.3779/j.issn.1009-3419.2009.01.009
Zhou, Y., Holland, M. J., Makalo, P., Joof, H., Roberts, C. H., Mabey, D. C., et al.
(2014). The conjunctival microbiome in health and trachomatous disease: a
case control study. Genome Med. 6:99. doi: 10.1186/s13073-014-0099-x
Zhu, J., Yamane, H., and Paul, W. E. (2010). Differentiation of
effector Cd4 T cell populations∗ . Annu. Rev. Immunol. 28, 445–489.
doi: 10.1146/annurev-immunol-030409-101212
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno,
M., et al. (2012). Pathogen-induced human Th17 cells produce Ifn-gamma or Il-
10 and are regulated by Il-1beta. Nature 484, 514–8. doi: 10.1038/nature10957
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Ramadhani, Derrick, Macleod, Massae, Mtuy, Jeffries, Roberts,
Bailey, Mabey, Holland and Burton. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 18 September 2017 | Volume 7 | Article 406
